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Abstract 
During embryonic development, pancreatic epithelial cells engage in concomitant 
morphogenetic and fate specification events that will give rise to the final organ 
architecture and functions. Cues from the surrounding microenvironment are known to 
influence the behaviour of epithelial progenitors and orchestrate these concomitant events 
throughout pancreas development. Nevertheless, the composition of the pancreatic 
microenvironment remains elusive; also, the interplay between components of the 
surrounding microenvironment and the epithelium is poorly characterized. 
We present here a comprehensive overview of the pancreatic microenvironment and what 
is known regarding distinct cell types, signaling molecules, ECM, that constitute it.  We 
focus on the molecular circuits governing cell-cell interactions, which are at play in the 
developing pancreas, controlling pancreatic progenitor proliferation, morphogenesis, and 
differentiation. Finally, open questions and implication of future research in this field are 
discussed in the context of pancreatic diseases, such as diabetes and cancer, as well as 
therapeutic approaches for these diseases. 
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The adult pancreas is a composite organ responsible for two vital functions in our body: 
production of digestive enzymes and glucose metabolism (Slack, 1995). The exocrine 
portion of the pancreas is composed of acinar and ductal cells, which produce and collect, 
respectively, the enzymes that facilitate nutrient absorption in the gut. The acinar cells 
secrete important enzymes for the catalysis of proteins, lipids and carbohydrates. The 
bicarbonate- and mucin-secreting ductal cells form a complex ductal network allowing the 
release of the pancreatic secretions into the duodenum. The endocrine compartment is 
organized into the islets of Langerhans and is responsible for the production and secretion 
of glucose modulating hormones in the systemic circulation. The most abundant cell type 
in human and mouse islets are the insulin-producing b-cells (≥80%); the remaining fraction 
includes glucagon-producing α-cells, somatostatin-producing δ-cells and pancreatic 
polypeptide-producing PP cells (Pan and Wright, 2011; Slack, 1995). Islet-secreted 
hormones play a crucial role in the regulation of glucose homeostasis (Romer and Sussel, 
2015). 
The vital functions controlled by the pancreas are reflected in the morbidity and mortality 
associated with pancreatic diseases, such as diabetes and pancreatic cancer (Ellis et al., 
2017; Feig et al., 2012; Pociot and Lernmark, 2016; Zheng et al., 2018). Diabetes is 
generally characterized by hyperglycemia due to loss or dysfunction of the endocrine b-
cells (Pociot and Lernmark, 2016). The challenge to curing diabetes relies on the replacing 
the lost or damaged insulin-producing β-cells in diabetic patients (Sneddon et al., 2018). 
On the other hand, the exocrine compartment is the target of pancreatitis and pancreatic 
ductal adenocarcinoma (PDAC), which is a devastating malignancy with an extremely poor 
prognosis and unmet medical need (Feig et al., 2012; Sinha and Leach, 2016). Work from 
the past two decades clearly showed how much the understanding of the mechanisms 
underlying pancreas formation has helped elucidating the pathogenesis of pancreatic 
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diseases and developing therapeutic strategies for these diseases. Hence, remarkable 
advances in generating a sustainable source of functional human stem cell-derived insulin-
producing cells for cell transplantation have been made thanks to the identification of 
developmental factors, which are released from the pancreatic microenvironment and 
regulate expansion and differentiation of pancreatic cells (Sneddon et al., 2018). 
Moreover, aberrant activation of embryonic signaling pathways is frequent in PDAC, 
making developmental regulators therapeutically attractive (Biankin et al., 2012; Roy et al., 
2016).  
In this review, we focus on the pancreatic microenvironment and its different components 
with a particular emphasis on their interplay with the epithelium during pancreas 
organogenesis. We draw mainly from findings in the mouse model, but that are conserved 
in other model organisms, including in humans. We discuss the implications of these 
findings in the context of pancreatic diseases and therapeutic approaches. 
 
Overview of embryonic pancreas development 
Many excellent and comprehensive reviews have been written on the transcriptional 
control underlying pancreas development (Arda et al., 2013; Jørgensen et al., 2006; 
Larsen and Grapin-Botton, 2017; Pan and Wright, 2011; Shih et al., 2013; Slack, 1995). 
Here, we provide only a brief overview of the key morphogenetic events and transcription 
factors (TF) important for establishing pancreatic cell identity.  
The pancreas, together with the liver, biliary system, lung, thymus, thyroid and epithelial 
cells lining the respiratory and digestive systems, originates from the endoderm germ layer 
(Slack, 1995; Spagnoli, 2007; Zorn and Wells, 2007). Pancreatic fate specification occurs 
in the mouse embryo at approximately embryonic day (E)8.5-8.75, when the expression of 
the homeodomain TF Pancreatic and duodenal homeobox 1 (Pdx1) starts in two distinct 
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domains of the anterior region of the gut endoderm (a.k.a. foregut):  the ventral and dorsal 
anlagen (Slack, 1995; Spagnoli, 2007; Zorn and Wells, 2007). 
Commitment of endodermal cells to a pancreatic fate is a multistep process, involving a 
continuous crosstalk between the endoderm and surrounding tissues that eventually leads 
to the activation of a pancreatic gene expression program (Gittes, 2009; Spagnoli, 2007). 
At E9.5-10.5 in the mouse, mesenchymal cells condense around the two pancreatic buds, 
which consist of a pseudostratified epithelium positive for Pdx1 (Gittes, 2009; Landsman et 
al., 2011). Shortly after, at E11.5 pancreatic morphogenesis starts, allowing the pancreas 
to acquire the characteristic tree-like epithelial structure composed of a network of well-
formed branches and connected ducts, necessary to the organ to fulfill its exocrine 
functions (Larsen and Grapin-Botton, 2017; Shih et al., 2013).  Importantly, branching 
morphogenesis has been shown to be tightly coupled, both in a mechanistic and temporal 
manner, with growth and differentiation of the pancreatic cells (Larsen and Grapin-Botton, 
2017; Villasenor et al., 2012). The first step of this complex process is the acquisition of an 
apico-basal polarity from the pancreatic epithelial cell, which is dependent on the Rho 
GTPase Cdc42 (Kesavan et al., 2009). Subsequently, some of these cells undergo apical 
constriction to form rosette structures with microlumens at the center (Hick et al., 2009; 
Villasenor et al., 2012). Microlumen formation and subsequent epithelial remodeling further 
depends on Eph/ephrin signalling (Villasenor et al., 2012). Moreover, actin cytoskeleton 
remodeling underlies apical constriction in pancreatic progenitors; this is regulated by Rho 
and the RhoGAP Stard13, whose disruption leads to reduced epithelial branching and 
associated pancreatic growth defects in the mouse (Petzold et al., 2013). Around E12.5, 
the fusion of the microlumina allows the establishment of primary branches, which 
subsequently undergo a combination of lateral branching and tip-splitting to generate a 
complex tubular plexus (Hick et al., 2009; Pan and Wright, 2011; Puri and Hebrok, 2007; 
Villasenor et al., 2012). This coincides with a gradual spatial segregation of the multipotent 
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pancreatic progenitor cells (MPC) and establishment of distinct pancreatic lineages. MPCs 
initially co-express a set of pancreatic TFs, including Pdx1, Pancreatic-specific 
Transcription Factor 1a (Ptf1a), SRY-box 9 (Sox9), and Hepatocyte nuclear factor 1β 
(Hnf1β) (Ahlgren et al., 1997; Arda et al., 2013; Haumaitre et al., 2005; Kawaguchi et al., 
2002; Offield et al., 1996; Seymour et al., 2007). After E12.5, pancreatic epithelial cells 
organize themselves in two different domains, called “tip” and “trunk” domains: the tip 
domain is marked by the expression of Ptf1a, Gata4, c-myc and Cpa1, and gives rise to 
acinar cells (Pan and Wright, 2011; Zhou et al., 2007), whereas the trunk region contains 
bipotent cells that are committed to become ductal and endocrine cells and express Nkx6 
homeobox 1 (Nkx6.1), Nkx6.2, Sox9, Hnf1β, Gata6 and Hairy and enhancer of split (Hes1) 
(Haumaitre et al., 2005; Henseleit et al., 2005; Jensen et al., 2000; Sander et al., 2000; 
Seymour et al., 2007; Solar et al., 2009). The mechanisms responsible for this early 
regionalization and underlying signaling pathways remain unknown. In other developing 
organ systems, focal sources of morphogens in the surrounding mesenchyme were shown 
to establish distinct gene expression domains (Hogan, 1999). If and how the pancreatic 
mesenchyme establishes “niche-like” environments responsible for distinct differentiation 
program and tissue-regionalization remain open questions.  
Subsequently, following gut rotation, the ventral bud moves distally and fuses with the 
dorsal bud to form a single nascent pancreas (Jørgensen et al., 2006; Slack, 1995). This 
coincides with the major wave of pancreatic cell differentiation in a process known as 
“secondary transition” (Larsen and Grapin-Botton, 2017; Pan and Wright, 2011; Shih et al., 
2013). Acinar cells at the tips of the branches begin expressing digestive enzymes, such 
as Elastase and Amylase (Pan and Wright, 2011). Within the trunk compartment, bipotent 
progenitor cells are directed into endocrine fate by induction of Neurogenin 3 (Ngn3), 
whereas those that do not activate Ngn3 will differentiate along the ductal compartment 
pathway (Gouzi et al., 2011; Magenheim et al., 2011b; Solar et al., 2009). Once Ngn3 
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transcription has initiated, it triggers exit from the cell cycle and delamination from the 
trunk into the surrounding mesenchyme where the endocrine progenitors will differentiate 
into the five different endocrine cell types (Gouzi et al., 2011; Larsen and Grapin-Botton, 
2017; Miyatsuka et al., 2011). How the activation or repression of Ngn3 in ductal cells is 
mechanistically achieved is still under active investigation (Bankaitis et al., 2015; Larsen 
and Grapin-Botton, 2017; Löf-Öhlin et al., 2017). The level of Notch signaling has been 
demonstrated to exert antagonistic effects on Neurog3 transcription. The Notch target and 
effector Hes1 has been shown to repress Ngn3 transcription and accelerate Ngn3 protein 
degradation (Jensen et al., 2000; Larsen and Grapin-Botton, 2017; Qu et al., 2013); but, 
how different trunk cells acquire different Notch activation levels is still unknown. Ngn3 
activates a set of TFs, which, in turn, control further differentiation of endocrine progenitor 
cells into the five endocrine cell types, such as the LIM homeobox transcription factor 
Islet1 (Isl1), Nkx2.2, Insulinoma-associated 1 (Insm1), Rfx6 and Neurogenic differentiation 
1 (NeuroD1)  (Ahlgren et al., 1997; Mastracci et al., 2013; Osipovich et al., 2014; Romer 
and Sussel, 2015). 
Of note, the majority of these TFs plays multiple roles in pancreatic development as well 
as in the adult organ, implying that the same TF can exert different functions depending on 
the cellular context. For instance, TFs that are required for β-cell differentiation, such as 
Pdx1 and Nkx6.1, must be actively maintained throughout the cell’s lifetime; indeed, their 
loss triggers β-cell de-differentiation or switch of identity (Gao et al., 2014; Romer and 
Sussel, 2015; Taylor et al., 2013). Importantly, the same events as well as transcriptional 
silencing of these TFs have recently emerged to be associated with β-dysfunction and 
Type 2 diabetes (T2D) in humans (reviewed in (Romer and Sussel, 2015), stressing the 
relevance of further elucidating the islet-cell specific transcriptional networks.  
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The pancreatic microenvironment  
During embryonic development, the pancreatic microenvironment is composed of multiple 
cell types, including mesenchymal cells, endothelial cells, neural crest-derived and 
immune cells, as well as structural molecules, which are part of the extracellular matrix 
(ECM) (Azizoglu and Cleaver, 2016; Gittes, 2009; Hisaoka et al., 1993; Landsman et al., 
2011; Nekrep et al., 2008; Pierreux et al., 2010; Shih et al., 2016) (Fig. 1). Most of these 
components may exert distinct roles at subsequent steps of pancreatic development, 
influencing fate specification, growth, morphogenesis and/or differentiation. External inputs 
from the pancreatic microenvironment, including signaling effectors and cell interactions, 
and their impact(s) on pancreatic epithelial cells at different developmental stages are 
discussed in the following sections. 
 
Early tissue interactions underlying pancreatic fate specification 
Studies in different vertebrate species have shown that during gastrulation instructive 
signals from the adjacent germ layers, including Fibroblast Growth Factor (FGF), Retinoic 
Acid (RA), Bone Morphogenetic Protein (BMP), render the endoderm competent to receive 
subsequent pro-pancreatic signals signaling effectors (Spagnoli, 2007; Zorn and Wells, 
2007). After gastrulation, once the foregut endoderm has completed its ventral closure, the 
prospective pancreatic endoderm is exposed to a series of tissue interactions, which are 
required for its fate specification (Pan and Wright, 2011; Shih et al., 2013; Spagnoli, 2007). 
Interestingly, because the organ arises from two separate endoderm domains, different 
tissue interactions are established during early development. Specifically, the dorsal bud is 
in contact with the notochord and dorsal aorta, while the ventral buds with lateral plate 
mesoderm, cardiac mesoderm and vitelline veins (Deutsch et al., 2001; Gittes, 2009; 
Hebrok et al., 1998; Kim et al., 1997; Kumar et al., 2003; Lammert et al., 2001; Yoshitomi 
and Zaret, 2004). Despite these contrasting local niches and some transcriptional 
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heterogeneity revealed by bulk and single-cell RNASeq (Li et al., 2018; Rodríguez-Seguel 
et al., 2013), both pancreatic buds possess the ability to differentiate into all pancreatic cell 
types, suggesting that different developmental cues can be used to promote pancreatic 
fate.   
The notochord lies next to the dorsal midline endoderm and remains in contact with the 
dorsal pancreatic endoderm until E8 in the mouse embryo, when it is displaced by the 
fusion of the paired dorsal aortas (Lammert et al., 2001; Slack, 1995). Seminal studies in 
the chick showed that the notochord is required and sufficient for pancreatic fate induction 
(Hebrok et al., 1998; Kim et al., 1997). Removal of the notochord in explanted chick 
embryos prevents dorsal pancreas formation, due to an ectopic expression of Sonic 
Hedgehog (Shh) in the pancreatic region (Hebrok et al., 1998; Kim et al., 1997). 
Conversely, grafting an ectopic notochord adjacent to the ventral foregut in a chick embryo 
results into suppression of endodermal Shh together with induction of pancreas formation. 
Additionally, these studies discovered that Activin-βB and FGF2 are the morphogens 
released by the chick notochord and responsible for repression of Shh expression in the 
pre-pancreatic region, allowing the initiation of pancreatic gene expression (Hebrok et al., 
1998; Kim et al., 1997). Consistently, mouse mutants for ActRIIA and ActRIIB activin 
receptors exhibit pancreatic hypoplasia and defects in foregut patterning (Kim et al., 2000). 
Finally, gain-of-function studies of the Shh pathway in the mouse further established its 
role as repressor of pancreatic fate. Specifically, inactivation of two Hedgehog inhibitors, 
the receptor Patched 1 (Ptch1) and Hedgehog-interacting protein (Hhip), leads to 
increased Hedgehog signaling and disruption of pancreas formation (Kawahira et al., 
2003; Kawahira et al., 2005). Also, ectopic expression of Shh in the pancreatic endoderm 
induces partial conversion of the endoderm into duodenal fate and change in identity of the 
surrounding pancreatic mesenchyme (Apelqvist et al., 1997). 
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Subsequently, around E9 in the mouse embryo, the paired dorsal aortae start to fuse at 
the midline and become interposed between the notochord and the dorsal region of the 
foregut endoderm (Azizoglu and Cleaver, 2016; Lammert et al., 2001). The newly 
established contact with endothelial cells is important for proper dorsal pancreas formation 
(Lammert et al., 2001; Yoshitomi and Zaret, 2004). In vitro tissue recombination 
experiments showed that aortic endothelial cells induce Pdx1 and insulin expression in the 
adjacent dorsal endoderm, together with formation of structures resembling pancreatic 
tissue (Lammert et al., 2001). However, in vivo studies in mouse embryos null for Flk1 
[encoding Vascular Endothelial Growth Factor receptor (VEGFR) 2], which lack all 
endothelial cells, indicated that aortic endothelial cells are not required for the induction of 
Pdx1 in the dorsal foregut, but for the later Ptf1a expression and expansion of the dorsal 
bud (Jacquemin et al., 2006; Yoshitomi and Zaret, 2004). Moreover, stimuli produced by 
the aorta are essential for the survival of the dorsal mesenchyme, which in turn influences 
dorsal pancreas development (Jacquemin et al., 2006; Yoshitomi and Zaret, 2004). 
Retinoic acid (RA) also exerts a conserved role in pancreatic fate induction of the dorsal 
endoderm but not of the ventral bud (Arregi et al., 2016; Chen et al., 2004; Kumar et al., 
2003; Martín et al., 2005; Stafford and Prince, 2002) (see below in “The pancreatic 
mesenchyme” section). 
The ventral region of the foregut is exposed to a different set of interactions, including with 
the lateral plate mesoderm and its derivatives, the cardiac mesoderm and septum 
transversum mesenchyme as well as to the vitelline veins (Azizoglu and Cleaver, 2016; 
Deutsch et al., 2001; Gualdi et al., 1996; Lammert et al., 2001). These unique interactions 
are primarily important for the lineage restriction between liver and pancreas cell fate 
within the ventral foregut endoderm (Deutsch et al., 2001; Gualdi et al., 1996; Wandzioch 
and Zaret, 2009). The ventral foregut endoderm contains a putative bipotent hepato-
pancreatic progenitor population, which by default is fated to adopt a pancreatic fate 
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(Angelo et al., 2012; Deutsch et al., 2001; Rodríguez-Seguel et al., 2013; Tremblay and 
Zaret, 2005). Mouse foregut explants cultured in vitro activate pancreatic gene expression, 
while exposure to FGF- and BMP-mediated signalings from the cardiac mesoderm induces 
hepatic fate (Deutsch et al., 2001; Gualdi et al., 1996; Rossi et al., 2001). More 
specifically, BMP inhibition has been suggested to be necessary for inducing pancreatic 
cell fate, whereas both BMP and FGF signaling are required for hepatic cell fate 
acquisition within the ventral foregut in a conserved fashion across species (Chung et al., 
2008; Deutsch et al., 2001; Rossi et al., 2001; Spagnoli and Brivanlou, 2008). Zaret and 
colleagues discovered that the TF Hematopoietically expressed homeobox gene (Hex) 
helps to define the position of the prospective ventral pancreatic endoderm with respect to 
the cardiac mesoderm in the mouse (Bort et al., 2004). In the absence of Hex, ventral 
pancreatic progenitors fail to proliferate beyond the cardiac mesoderm to escape its 
hepatic-inducing signals and be specified (Bort et al., 2004). The establishment of proper 
levels of Wnt/β-catenin signaling and its temporal sequential activation in the anterior 
endoderm are also known to be essential for foregut identity and organ formation (Li et al., 
2008; Ober et al., 2006; Rodríguez-Seguel et al., 2013). Recent observations identified the 
non-canonical Wnt pathway as a developmental regulator of the liver versus pancreas fate 
decision, promoting pancreatic fate in the endoderm of Xenopus embryos and mouse ES 
cultures (Rodríguez-Seguel et al., 2013). 
The Hh pathway needs to be repressed during ventral pancreas fate specification, like in 
the dorsal bud, however this must occur via a notochord-independent mechanism (Gittes, 
2009; Hebrok et al., 2000). Recent observations from Sussel and colleagues showed that 
Shh expression is upregulated in the pancreatic endoderm upon Gata4/6 gene ablation, 
which results in arrested pancreatic development and cell fate switch of ventral pancreatic 
cells into intestinal fate and dorsal pancreas into stomach (Xuan and Sussel, 2016). This 
suggests a repressive interaction between Shh and the Gata4/6 TFs, representing a 
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unifying mechanism for dorsal and ventral pancreas fate specification (Xuan and Sussel, 
2016). 
 
The pancreatic mesenchyme 
Mesenchymal cells derived from the splanchnic mesoderm condense around the 
evaginating pancreatic epithelium at E10 in the mouse (Gittes, 2009; Landsman et al., 
2011). Seminal studies in the 1960s based on ex vivo tissue recombination experiments 
demonstrated the absolute requirement for pancreatic mesenchyme in epithelial growth 
and morphogenesis (Golosow and Grobstein, 1962; Wessells and Cohen, 1967). 
Subsequent ex vivo organ culture studies also revealed a critical role for the mesenchyme 
in pancreatic cell differentiation (Attali et al., 2007). Specifically, “naked epithelium” 
cultured in the absence of pancreatic mesenchyme sustains islet growth, while the 
presence of the pancreatic mesenchyme is required for induction of acinar fate (Miralles et 
al., 1998b). Only recently, Landsman et al. provided the first in vivo genetic evidence for 
the requirement of pancreatic mesenchyme throughout pancreas organogenesis in the 
mouse (Landsman et al., 2011). Combined use of Cre-lox technology with diphtheria toxin 
(DT)-induced apoptosis enabled tissue-specific depletion of pancreatic mesenchymal cells 
at different developmental stages in vivo (Landsman et al., 2011). Mesenchymal cells 
ablation at the onset of pancreas development results into pancreas agenesis, whereas 
depletion of mesenchymal cells at later stages leads to pancreatic hypoplasia and 
impaired epithelial morphogenesis, due to reduced epithelial proliferation (Landsman et al., 
2011). 
Even though the relevance of the mesenchyme during pancreatic organogenesis is well 
established, its embryonic origin is still elusive. Recent DiI fate mapping in mouse embryos 
cultured ex vivo suggests a common origin of dorsal and ventral pancreatic mesenchyme, 
both arising from a portion of the coelomic mesothelium (Angelo and Tremblay, 2018).  
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Yet, a common origin of the pancreatic mesenchyme is at odds with the differences 
reported so far between the transcriptional programs of dorsal and ventral 
mesenchyme(s). For instance, the TF Isl1 is expressed in the dorsal mesenchyme, but not 
in the ventral one (Ahlgren et al., 1997). Consistently, Isl1 gene deletion in the mouse 
leads to failure of dorsal mesenchyme development, which in turn affects dorsal Pdx1+ 
endoderm outgrowth and differentiation (Ahlgren et al., 1997). Similarly, N-cadherin 
(encoded by Cdh2) is expressed at high levels in the dorsal pancreatic mesenchyme 
starting from E9.5 and, subsequently, in the endocrine progenitors at E12.5, once 
delamination has started (Esni et al., 2001). Genetic ablation of Cdh2 results into dorsal 
pancreas agenesis due to impaired dorsal pancreatic mesenchyme survival (Esni et al., 
2001). Despite the similarities in expression pattern and mutant phenotypes, Isl1 and N-
cadherin seem to function independently, since Isl1 expression is unchanged in N-
cadherin-deficient mesenchyme (Esni et al., 2001). Future genetic lineage studies are 
required to further define the origin of the pancreatic mesenchyme and clarify if ventral and 
dorsal mesenchyme(s) share a common origin; the Dil-labeling results does not exclude 
the possibility of an additional mesenchymal source, as previously reported in other organs 
(Kfoury and Scadden, 2015; Lee et al., 2017; Zepp et al., 2017).  
The dorsal pancreatic mesenchyme not only is crucial for the development of the dorsal 
pancreatic epithelium, but it also contributes to spleen formation (Asayesh et al., 2006; 
Hecksher-Sørensen et al., 2004; Koss et al., 2012). Notably, the TFs Nkx3.2 and Nkx2.5, 
which initially mark dorsal pancreatic mesenchymal cells, become restricted to the spleen 
at E12.5, and mice mutants for these genes are asplenic (Asayesh et al., 2006; Koss et 
al., 2012). Specifically, in the absence of Nkx3.2 the splenic mesenchyme fails to 
condense and does not segregate from the pancreas, resulting in metaplastic 
transformation of the pancreatic epithelium and mesenchyme into intestinal-like tissue, 
possibly due to ectopic Shh-espression (Asayesh et al., 2006; Hecksher-Sørensen et al., 
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2004).  Interestingly, rare human congenital disorders present concurrent splenic defects 
(asplenia or polyspenia) and dorsal pancreatic aplasia/hypoplasia is likely to be explained 
by the common origin of the splenic and pancreatic mesenchyme (Drut et al., 1993; Hadar 
et al., 1991; Herman and Siegel, 1991; Kim et al., 2009; Low et al., 2011; Sener and Alper, 
1994; Sriplung, 1991; Wainwright and Nelson, 1993). 
 
Mesenchymal signaling molecules 
To date, several signaling molecules have been identified to be released by pancreatic 
mesenchymal cells and participate in the epithelial-mesenchymal crosstalk during 
pancreatic development. Often these signaling molecules exert distinct roles during 
development, influencing either the expansion of epithelial progenitors, their differentiation 
or both. A selection of the major signaling pathways involved in the pancreatic epithelial-
mesenchymal crosstalk is reviewed in the following section.  
 
FGF signaling pathway 
In the mouse embryo from E9.5 onward, different members of the Fgf family are 
expressed in the pancreatic mesenchyme, including Fgf1, Fgf7 and Fgf10, whereas the 
Fgf receptor 2b (Fgfr2b) and Fgfr3 are expressed in the pancreatic epithelium (Arnaud-
Dabernat et al., 2007; Bhushan et al., 2001; Miralles et al., 1999; Ye et al., 2005). FGF10 
is among the best characterized signaling molecules in the pancreatic mesenchyme and 
its function has been extensively studied both ex vivo in pancreatic explants as well as in 
vivo in the mouse. Fgf10-/- embryos display severe pancreatic hypoplasia both dorsally 
and ventrally, due to failure of proliferation of specified Pdx1+ progenitors (Bhushan et al., 
2001). Consistently, the pancreas in Fgfr2b-/- embryos is smaller than in wild-type 
littermates and pancreatic ductal branching as well as duct cell proliferation are 
significantly reduced, even though to a lesser extent than in the absence of FGF10 
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(Pulkkinen et al., 2003).  Further investigation showed that Fgf10 is required for the 
maintenance of Pdx1 expression and induction of Ptf1a in MPCs (Jacquemin et al., 2006). 
A more recent study identified a relationship between FGF10 and another the pancreatic 
TF, Sox9, which is required for progenitor proliferation and survival (Seymour et al., 2012). 
Specifically, mesenchymal-derived FGF10, transduced through the FGFR2B receptor, 
sustains Sox9 expression in the epithelium, which in turn is required for Fgfr2b expression 
and, therefore, FGF10 response (Seymour et al., 2012). Mechanistically, this process 
involves a SOX9/FGF10/FGFR2B feed-forward loop in the maintenance of pancreatic 
identity, and its perturbation results into loss of pancreatic cell identity and conversion into 
liver fate (Seymour et al., 2012). Interestingly, such a functional relationship between 
FGF10 and Sox9 is conserved in zebrafish embryos, where combined action of FGF10 
and Sox9 is essential for the morphogenesis of the hepatopancreatic ducts and prevents 
pancreatic, hepatic and intestinal cell plasticity (Dong et al., 2007; Manfroid et al., 2007). 
Unlike the other FGFR-driven signaling, FGFR3 has been reported to inhibit the expansion 
of the pancreatic epithelium (Arnaud-Dabernat et al., 2007). Likely, these differences in 
activities reflect temporal changes in expression of the signaling components and the 
dynamic nature of cellular competence in response to extracellular signals. 
 
TGFβ / BMP signaling pathway 
The TGFβ ligands, Tgfβ1, Tgfβ2 and Tgfβ3, are expressed in the mouse pancreatic 
epithelium starting from E12.5, becoming subsequently restricted to the acinar cells 
(Crisera et al., 2000; Gittes, 2009). At the same embryonic stage, the TGFβ receptors, 
Tgfbr1 and Tgfbr2, show an expression pattern similar to their ligands, but localize to 
ductal cells as development proceeds (Gittes, 2009; Tulachan et al., 2007). In addition, 
Tgfbr1 is also expressed in the pancreatic mesenchyme at early stages (Tulachan et al., 
2007). Multiple studies supported a role for TGFβ in the process of delamination of 
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endocrine progenitors from the trunk compartment into the surrounding mesenchyme and 
consequent coalescence into islets (Miralles et al., 1998a; Sanvito et al., 1995; Tulachan 
et al., 2007). In particular, TGFβ1 has been shown to control the activity of Matrix 
metalloproteinase-2 (MMP-2) and islet morphogenesis in vitro (Miralles et al., 1998a).  
Activins and their receptors are important in the early foregut endoderm for pancreatic 
specification (see above), but also for endocrine differentiation at later stages (Maldonado 
et al., 2000; Verschueren et al., 1995). In particular, the ligands Activins A and B localize 
to the developing endocrine cells, being enriched in the glucagon-expressing a-cells 
(Maldonado et al., 2000). Activin receptor type IIB (Acvr2b) and Activin receptor type IIA 
(Acvr2a) mutant mice display pancreatic hypoplasia with reduced number of endocrine 
cells, which in turn lead to hypoplastic islets (Kim et al., 2000). Moreover, ex vivo treatment 
of mouse pancreatic explants with recombinant Activin results in reduced branching 
morphogenesis and an increased number of insulin-expressing cells (Demeterco et al., 
2000; Ritvos et al., 1995). Consistently, when pancreatic explants are treated with 
Follistatin, a well-known Activin antagonist, cells undergo enhanced exocrine 
differentiation at the expenses of the endocrine cell lineage (Miralles et al., 1998b). 
BMP molecules are also expressed in the developing pancreas and have been suggested 
to regulate the development of both pancreatic epithelium and mesenchyme (Ahnfelt-
Rønne et al., 2010; Dichmann et al., 2003; Goulley et al., 2007). Bmp signaling is 
repeatedly used in this developmental process, exerting different, sometimes even 
opposite, actions. At early developmental stages, BMP is antagonistic to pancreatic fate 
and acts as a pro-hepatic factor, as seen in multiple vertebrate species, while few hours 
later it has opposite effects, promoting adoption of pancreatic fate in mouse foregut 
explants (Chung et al., 2008; Deutsch et al., 2001; Rossi et al., 2001; Spagnoli and 
Brivanlou, 2008; Wandzioch and Zaret, 2009). Additionally, conditional deletion of the BMP 
receptor 1A (ALK3) in insulin-positive cells identified a role for BMP in glucose-stimulated 
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insulin secretion in the mouse adult pancreas (Goulley et al., 2007). Similarly, ectopic 
expression of BMP inhibitors, such as Noggin and Smad6, under the Pdx1 promoter 
results into glucose intolerance and diabetes, but normal pancreatic morphology (Goulley 
et al., 2007). 
Likewise, in mouse or human ES cultures differentiating along the pancreatic cell lineage 
BMP exert versatile functions. While inhibition of BMP is important for inducing pancreatic 
fate specification from pluripotent ESCs, the late exposure of induced pancreatic 
progenitors to BMP inhibitors helps to ensure precise temporal activation of NEUROG3, 
favoring the generation of mono-hormonal insulin-secreting cells versus polyhormonal 
cells (D'Amour et al., 2006; Kroon et al., 2008; Mfopou et al., 2010; Russ et al., 2015).  
The intracellular mediators of BMP and TGFβ signaling are the SMAD molecules 
(Massagué et al., 2005). SMAD1, SMAD5 and SMAD8 are activated by BMP and, 
specifically, inhibited by SMAD6, whereas SMAD2 and SMAD3 are downstream of TGFβ 
isoforms and Activin. Beside a short window of time at E8.5, when phosphorylated (active)  
(p)-Smad1,5,8 has been reported in the foregut endoderm (Wandzioch and Zaret, 2009), 
BMP-mediated Smad activation seems entirely restricted to the mesenchyme of both 
chicken and mouse pancreas at subsequent stages (Ahnfelt-Rønne et al., 2010). 
Consistently, ex vivo studies in mouse explants indicate that BMP signaling is primarily 
required in the mesenchyme and that the effects on the epithelium might be indirect 
(Ahnfelt-Rønne et al., 2010). 
Together these findings underscore once more the importance of time in signaling events 
and changes of cellular competence in response to extracellular signals. It is also unclear 
how BMPs mediate such a wide variety of responses. It may be, for instance, a result of 
diversity in the components of signal transduction or crosstalk with other pathways. 
Possibly, better in vivo models for fine-tuned spatio-temporal control and precise 
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manipulation of signaling pathways at key developmental-equivalent stages are required to 
answer these questions. 
 
Notch signaling pathway 
Notch receptors and ligands are expressed in the developing pancreas starting from E9.5 
in the mouse pancreatic epithelium, with the exception of Notch 3 and Notch 4, which are 
in mesenchymal and endothelial cells, respectively (Lammert et al., 2000).  
At early stages, Notch signaling is necessary to maintain proliferation of the 
undifferentiated pancreatic progenitors and prevent endocrine and exocrine differentiation, 
acting in a conserved fashion across species (Ahnfelt-Rønne et al., 2007; Apelqvist et al., 
1999; Jensen et al., 2000; Murtaugh et al., 2003). Null mutant mice for either Notch ligand 
genes, such as Dll1, or for Notch target genes, like Rbpj-k and Hes1, display pancreatic 
hypoplasia due to accelerated and increased endocrine differentiation (Apelqvist et al., 
1999; Jensen et al., 2000). Moreover, constitutive expression of an active intracellular 
domain of Notch1 under the control of the Pdx1 promoter results into failure of endocrine 
and exocrine differentiation, which is accompanied by expansion of the pancreatic 
progenitor number (Murtaugh et al., 2003). 
An interplay between Notch and FGF signaling has been reported, whereby FGF10 would 
maintain active Notch signaling to control epithelial cell proliferation and differentiation 
(Hart et al., 2003; Norgaard et al., 2003). Specifically, Notch signaling controls proliferation 
of pancreatic progenitors downstream of FGF10 through Hes1 transcriptional control of 
Cdkn1c (Georgia et al., 2006; Miralles et al., 2006; Norgaard et al., 2003). In contrast, 
endocrine and exocrine cells are induced within ductal epithelium via Notch signaling by 
lateral inhibition (Ahnfelt-Rønne et al., 2012; Apelqvist et al., 1999; Murtaugh et al., 2003). 
The mechanism through which Notch controls endocrine differentiation involves a Hes1-
dependent suppression of Ngn3 expression, whereas its modulation of acinar 
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differentiation depends on the inhibition of PTF1a (Ahnfelt-Rønne et al., 2012; Esni et al., 
2004; Murtaugh et al., 2003). 
 
Hedgehog signaling pathway 
Hh signaling needs to be tightly-regulated throughout pancreas development. Pancreas 
fate specification requires suppression of Hh signaling activation in the foregut endoderm 
(see above) (Hebrok et al., 2000; Kim et al., 1997). Subsequently in development, 
disrupted Hh signaling affects the development of both endocrine and exocrine cells and 
impairs β-cell function and mass (Hebrok et al., 2000; Kawahira et al., 2003; Kawahira et 
al., 2005). Efforts have been made to differentiate between Hh signaling contribution to 
pancreas epithelium and mesenchyme. Manipulation of the pathway in epithelial and β-
cells showed a cell-autonomous role of Hh signalling in regulating endocrine mass and β-
cell function (Thomas et al., 2001; Thomas et al., 2000). More recent work from Landsman 
and colleagues has provided direct evidence for non-autonomous roles of the Hh pathway 
in pancreatic development (Hibsher et al., 2016). Specifically, by deleting the receptor 
Ptch1 in the pancreatic mesenchyme, Shh signalling activity is increased, due to the 
abrogation of the inhibitory function of Ptch1 on Smoothened. Such deregulated Hh 
signaling in mesenchymal cells leads to hyperplasia of the pancreatic mesenchyme along 
with disrupted epithelial growth and islet cellular composition (Hibsher et al., 2016). How 
the Hh pathway signals in the mesenchyme is unknown. It is unclear whether the epithelial 
defects are consequences of the mesenchymal hyperplasia, which might hamper proper 
mesenchymal-epithelial interactions. Finally, Hh-dependent mesenchymal cues that 
regulate pancreatic growth and differentiation are yet to be identified. 
 
Retinoids signaling pathway 
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Vitamin A-derived RA, retinoid binding proteins and RA receptors are expressed in both 
pancreatic epithelium and mesenchyme during pancreas development (Arregi et al., 2016; 
Martín et al., 2005; Molotkov et al., 2005; Stafford and Prince, 2002; Tulachan et al., 
2003). Specifically, the enzymes RDH10 and RALDH2, responsible for the production of 
RA, are present in the lateral plate mesoderm at E8.25, before Pdx1 induction, and later in 
the pancreatic mesenchyme (Arregi et al., 2016; Martín et al., 2005; Molotkov et al., 2005; 
Stafford and Prince, 2002; Tulachan et al., 2003). 
In vertebrate species, including zebrafish, Xenopus and mouse, mesoderm-derived RA 
signaling induces pancreatic specification within the endoderm. Deletion of Rdh10 or 
Raldh2 as well as expression of dominant-negative RA receptors result into impaired 
pancreatic specification within the dorsal foregut endoderm (Arregi et al., 2016; Chen et 
al., 2004; Martín et al., 2005; Molotkov et al., 2005; Stafford and Prince, 2002; Tulachan et 
al., 2003). Later in the mouse embryo, RA has been shown to control endocrine and ductal 
differentiation and influence ductal versus acinar cell fate decision (Arregi et al., 2016). 
Specifically, endoderm specific-Rdh10 deletion results into pancreatic hypoplasia with 
impaired endocrine differentiation observed at later stages  (Arregi et al., 2016). 
Consistently, treatment of embryonic pancreatic explants with RA promotes ductal cell 
differentiation with premature formation of endocrine clusters at the expense of exocrine 
differentiation and branching morphogenesis (Shen et al., 2007; Tulachan et al., 2003). 
Interestingly, in Rdh10 and Raldh2 null mutant embryos the dorsal pancreatic 
mesenchyme is also disrupted, suggesting a further role of RA signaling in formation and 
patterning of mesenchymal cells (Arregi et al., 2016; Martín et al., 2005). Yet, specific 
mesenchymal contribution of the RA signaling has not been investigated and the 
distinction between cell-autonomous and non-cell-autonomous contributions need to be 
addressed.  
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Epidermal growth factor (EGF) signaling pathway 
EGF receptors (EGFR) and EGF ligands are present in both epithelium and mesenchyme 
of the developing pancreas and the pathway has a role in pancreatic morphogenesis and 
differentiation (Gittes, 2009; Kritzik et al., 2000). Egfr KO mouse embryos display impaired 
branching morphogenesis, due to proliferation defects, and delayed endocrine 
differentiation with perturbed islet formation (Miettinen et al., 2000). Moreover, 
overexpression of a dominant-negative form of Egfr under the Pdx1-promoter results into 
impaired postnatal β-cell proliferation and diabetes (Miettinen et al., 2000; Miettinen et al., 
2006). In addition to Egfr, the Erbb4 receptor is expressed in pancreatic epithelial cells at 
E12.5 and becomes restricted to the ductal epithelium by E16.5 (Kritzik et al., 2000). This 
receptor has been suggested to play a role in δ-cell development, since treatment of 
pancreatic explants with an antibody neutralizing Neuregulin 4, the Erbb4 ligand, 
specifically blocked δ-cell expansion (Huotari et al., 2002).  
Recent work by Semb and colleagues has started shedding light into how EGFR signaling 
coordinates epithelial morphogenesis and cell differentiation in the pancreas (Löf-Öhlin et 
al., 2017). They identified an interesting and conserved mechanism whereby EGF/EGFR 
signaling controls β-cell differentiation via modulation of apical polarity in endocrine 
progenitor cells. Morevover, they reported sequential temporal activation of the EGFR by 
distinct EGF ligands during pancreas development (Löf-Öhlin et al., 2017). Specifically, 
during the primary transition (E9.5-E12) EGF ligand counteracts polarization of pancreatic 
epithelial progenitors, while later Betacellulin (BTC) ligand appears to induce β-cell 
commitment by reducing the apical domain size during the secondary transition. Apical 
domain constriction results into reduced Notch signaling, increased Ngn3 expression and 
β-cell differentiation (Löf-Öhlin et al., 2017). 
  
Hepatocyte growth factor (HGF) signaling pathway 
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Hgf and its receptor Met are expressed in the pancreatic mesenchyme and epithelium, 
respectively (Garcia-Ocaña et al., 2000; Otonkoski et al., 1996). HGF signaling was shown 
to induce β-cell formation both in vitro and in vivo, including in human fetal pancreas 
cultures (Garcia-Ocaña et al., 2000; Otonkoski et al., 1996). Moreover, transgenic mice 
expressing Hgf under the rat insulin promoter display an increase in islet number with 
enhanced insulin content (Garcia-Ocaña et al., 2000). Consistently, deletion of Met in β-
cells results in mice that exhibit glucose intolerance with reduced insulin secretion and islet 
size (Dai et al., 2005; Roccisana et al., 2005).  
Interestingly, recent findings in zebrafish suggest a role for HGF-Met signaling in pancreas 
morphogenesis through control of directional migration of pancreatic progenitors 
(Anderson et al., 2013). If a similar mechanism contributes to pancreatic branching 
morphogenesis in mammals remains to be tested. 
 
Wnt signaling pathway 
In the developing pancreas, Wnt signaling plays multiple roles that are spatially and 
temporally restricted. An early role for Wnt signaling in pancreatic fate specification has 
been described in Xenopus and mouse embryos (see above) (McLin et al., 2007; 
Rodríguez-Seguel et al., 2013). In the frog, canonical Wnt signaling needs to be repressed 
in the anterior endoderm in order to maintain foregut identity and allow pancreas and liver 
development (McLin et al., 2007). Once the foregut territory has been established, the 
non-canonical Wnt signaling regulates the pancreas versus liver cell fate decision in both 
Xenopus and mouse (Rodríguez-Seguel et al., 2013). In particular, non-canonical Wnt 
family members, such as Wnt5a, display a differential expression pattern between 
pancreatic and hepatic progenitors within the foregut endoderm (Rodríguez-Seguel et al., 
2013). Consistently, Wnt5A treatment of Xenopus endodermal cells and mouse ESC 
(mESC) cells induce Pdx1 expression (Rodríguez-Seguel et al., 2013). 
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Subsequently, several Wnt ligands localize in the mouse pancreatic mesenchyme, 
whereas Frizzled receptors (Fzd) and secreted Frizzled-Related Proteins (SFRP) are 
present in both the epithelium and mesenchyme (Heller et al., 2002). Mice overexpressing 
Wnt1 and Wnt5a under the control of the Pdx1 promoter display pancreatic agenesis and 
pancreatic hypoplasia, respectively, which is in line with its early role in foregut 
specification (Heller et al., 2002). Similarly, constitutive activation of β-catenin at early 
stages of pancreatic development leads to dramatic pancreatic hypoplasia (Heiser et al., 
2006). By contrast, ablation of β-catenin in Pdx1-expressing pancreatic progenitors 
reduces epithelial proliferation and, specifically, prevents exocrine differentiation 
(Murtaugh et al., 2005). Consistently, inhibition of Wnt activity by expressing a soluble form 
of Fzd8 under the Pdx1 promoter results into a reduced number of proliferating pancreatic 
progenitor cells and organ hypoplasia, affecting both exocrine and endocrine 
compartments in mice (Papadopoulou and Edlund, 2005).   
Interestingly, Wnt signaling is also an essential mediator of pancreatic mesenchymal cell 
survival. Specific inactivation of canonical Wnt signalling in the pancreatic mesenchyme, 
using β-cateninfl/fl;Nkx3.2-Cre Tg embryos, results in the loss of mesenchymal cells, which 
in turn affects the epithelium (Landsman et al., 2011). Consistently, a more recent study 
has identified Wnt7b ligand to be expressed in the epithelium and act as trophic factor for 
the mesenchyme via a paracrine mechanism from epithelium-to-mesenchyme (Afelik et 
al., 2015). Overall, because of the myriad of Wnt and Frizzled possible combinations as 
well as their diverse context-dependent functions, the complexity of the pathway deserves 
further attention. 
 
Taken together, most of the studies discussed in this section highlight the relevance of 
signaling pathways, many of which act concurrently, in epithelial-mesenchymal 
crosstalk(s) during pancreas organogenesis. The mechanisms by which these 
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mesenchymal signals are coordinated and integrated to stimulate epithelial progenitor 
proliferation and differentiation to produce functional pancreatic cells remain elusive. Also, 
whether is the developing pancreatic mesenchyme a homogenous tissue or composed of 
different mesenchymal cell populations, resembling distinct “cellular niches”, like in the 
haematopoietic and nervous system, lungs and skin, is unclear (Crane et al., 2017; Kfoury 
and Scadden, 2015; Lattanzi et al., 2015; Roberts et al., 2017; Zepp et al., 2017). If 
different niches exist, what TFs or intrinsic regulators confer spatio-temporal control of 
gene expression within the mesenchyme during pancreatic development is unknown.  
To date, only a small number of TFs have been reported in the embryonic pancreatic 
mesenchyme, including Isl1, Nkx3.2 and Hoxa6, Hoxb6 and Hoxc6 (Ahlgren et al., 1997; 
Asayesh et al., 2006; Hecksher-Sørensen et al., 2004; Landsman et al., 2011; Larsen et 
al., 2015). Isl1 is expressed in both pancreatic epithelium and mesenchyme and is 
required for dorsal mesenchyme formation (Ahlgren et al., 1997). Nkx3.2 (a.k.a. Bapx1) 
expression is in the splenopancreatic mesenchyme, but not in the epithelium (Asayesh et 
al., 2006; Hecksher-Sørensen et al., 2004). Null mutant embryos for Nkx3.2 displayed 
asplenia and metaplastic transformation of embryonic pancreas into intestinal-like tissue 
due to the loss of splenic mesenchyme condensation and separation (Asayesh et al., 
2006; Hecksher-Sørensen et al., 2004). More recently, the expression of Hox6 genes has 
been identified and studied in the mesenchymal compartment of the developing pancreas. 
Full KO embryos for all the three Hox6 paralogs results into impaired endocrine 
differentiation with disruption of branching morphogenesis (Larsen et al., 2015). To fully 
elucidate the identity and role(s) of mesenchymal genetic regulators driving pancreas 
development, future investigation are required using tools which enable fine-tuned gene 
manipulation in the mesenchyme. 
 
Extracellular matrix molecules 
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The basement membrane (BM) separates the epithelium from the surrounding 
mesenchyme and is crucial for epithelial tissue organization and function, including in the 
pancreas (Hisaoka et al., 1993). The BM is a fundamental site of interaction between 
epithelial cells and the ECM: the ECM mainly consists of fibronectin (FN), laminins and 
collagen-IV components, while the epithelium expresses multiple integrins molecules, 
which act as molecular hubs connecting the outside environment (mesenchyme) with the 
inside (epithelium) (Glentis et al., 2014; Guo and Giancotti, 2004; Hisaoka et al., 1993).  
During pancreas organogenesis, the BM controls branching morphogenesis and cell 
differentiation (Crisera et al., 2000; Jiang et al., 1999; Jiang et al., 2001; Shih et al., 2016). 
Disruption of cell-ECM interactions in pancreatic explant cultures using the tetrapeptide 
arginyl-glycyl-aspartyl-serine (RGDS), which competitively inhibits ECM-cell interactions, 
blocks branch formation (Shih et al., 2016). Moreover, substrates containing Laminin 1 
(a.k.a. Laminin 111) have been shown to induce pancreatic cell differentiation in ex vivo 
cultures (Jiang et al., 1999; Jiang et al., 2001). Consistent with this, several studies have 
suggested the requirement of integrins for initiation of branching morphogenesis, 
delamination of endocrine progenitors and islet formation. For instance, pancreatic-specific 
deletion of the β1-integrin subunit leads to impaired branching morphogenesis, due to BM 
defects and aberrant organization of the actin cytoskeleton (Shih et al., 2016). 
Furthermore, α6β4 and α5β1 integrin, together with Netrin, a Laminin soluble form, are 
important for pancreatic epithelial cell adhesion and migration in vitro (Yebra et al., 2003). 
Other integrins, such as αVβ5 and αVβ3, have been shown to interact with Fibronectin, 
Collagen-IV and Vitronectin to maintain ECM anchorage and allow cell migration in the 
human fetal pancreas (Cirulli et al., 2000). 
Taken together, these studies highlight the relevance of ECM and cell adhesion molecules 
as interfaces of signaling transmission within different compartments of the pancreas 
during the entire duration of its development. Microenvironmental signals transmitted via 
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the ECM might establish “niches” and mediate localized cellular behaviours in the 
embryonic pancreas. 
 
Blood vessels 
The physical interaction between the pancreatic epithelium and blood vessels is highly 
dynamic and changes throughout development (Azizoglu and Cleaver, 2016). During the 
primary transition (E9.5-E12), the pancreatic epithelium is avascular, with blood vessels 
only surrounding but not penetrating the epithelial buds (Pierreux et al., 2010). Starting 
with the secondary transition, blood vessels intercalate between the forming epithelial 
branches, either actively through angiogenesis or, passively, as the epithelium remodels 
(Pierreux et al., 2010). Moreover, the vessels follow a stereotypical pattern in their 
organization along the branches, becoming preferentially located near the central (trunk) 
epithelial cells and at a distance from the branch tips where acinar cells differentiate. This 
correlates with a predominant expression of the angiogenic factor Vascular Endothelial 
Growth Factor-A (VEGF-A) in trunk cells (Pierreux et al., 2010). In the mature organ, the 
branches of the pancreatic epithelium and the vascular systems closely intercalate, with 
densely vascularized islets connected to large vessels that run across the pancreas 
(Azizoglu and Cleaver, 2016). This constantly evolving relationship between blood vessels 
and pancreatic epithelium seems to influence different aspects of pancreas development 
(Azizoglu and Cleaver, 2016). While the early interaction with the aorta is crucial for 
pancreas fate specification (see above), at later stages endothelial cells restrict the growth 
of embryonic pancreas as wells as inhibit branching and differentiation (Jacquemin et al., 
2006; Lammert et al., 2001; Magenheim et al., 2011a; Pierreux et al., 2010; Sand et al., 
2011; Yoshitomi and Zaret, 2004). For instance, in vitro treatment of wild-type mouse 
pancreatic explants with VEGFA or VEGFR2-inhibitor leads to decreased exocrine 
proliferation or increased exocrine differentiation, respectively (Magenheim et al., 2011a; 
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Pierreux et al., 2010). Moreover, pancreatic explant cultures isolated from mouse 
transgenic embryos overexpressing Vegfa display hypervascularization with reduced 
exocrine differentiation (Pierreux et al., 2010). Similar effects have been reported in vivo in 
pancreata from E12.5 embryos overexpressing Vegfa (Magenheim et al., 2011a). In 
summary, blood vessels- and blood-derived signals play dynamic roles during pancreatic 
development either by direct signaling to the endoderm or indirectly through the 
mesenchyme. 
 
Neural crest derived-cells 
The neural crest (NC) cells are multipotent embryonic cells that arise from the dorsal 
neural tube and migrate to generate diverse ectodermal cell lineages (Young and 
Newgreen, 2001). Concomitant with the evagination of the pancreatic buds at E9, 
migrating NC cells reach the rostral foregut and, in a rostral-to-caudal migratory wave, 
populate the entire gut with progenitors of glial and neural cells (Young and Newgreen, 
2001). Approximately at E10, NC cells enter the pancreatic mesenchyme and intermingle 
with the pancreatic epithelium as it branches into the mesenchyme (Plank et al., 2011). 
Subsequently, these NC cells differentiate into glial Schwann cells that surround mature 
pancreatic islets and into neurons of the autonomic nervous system, both sympathetic and 
parasympathetic, that regulate islet function, such as insulin and glucagon secretion (Plank 
et al., 2011). Glial Cell Derived Neurotrophic Factor (GDNF), released from the pancreatic 
epithelium, has been proposed to act as a neurotrophic factor guiding the migration of 
neural progenitors into the pancreas (Muñoz-Bravo et al., 2013). 
To date, the role of NC-derived cells during pancreas development is not fully understood. 
Mouse mutants for two NC-specific TFs Forkhead Box D3 (Foxd3) and Paired Like 
Homeobox 2b (Phox2b) display loss of NC cells, which is accompanied by increased β-cell 
proliferation (Nekrep et al., 2008; Plank et al., 2011). Although the number is increased, 
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mutant β-cells display immature features, such as decreased expression of Mafa, Pdx1 
and Glut2 (Plank et al., 2011). Additionally, Phox2b(-/-) mutant embryos display 
upregulation of Nkx2.2 expression in the epithelium, suggesting a non-cell-autonomous 
feedback loop that links the neural crest with the pancreatic epithelium (Nekrep et al., 
2008). Indeed, analysis of Nkx2.2 KO embryos showed that signals from the pancreatic 
epithelium silence the expression of Phox2b in the NC-derived cells as they migrate into 
the pancreas (Nekrep et al., 2008). Perhaps, such inhibition is required for NC cells 
differentiation into specific cell types, like in the central nervous system. Altogether, these 
studies suggest that NC-derivatives negatively regulate β-cell proliferation and promote β-
cell maturation. 
 
Implications for directed differentiation of pluripotent stem cells into 
pancreatic b-cells 
Diabetes is a degenerative disease that affects over 400 million persons worldwide 
(http://www.who.int/diabetes/) (Ellis et al., 2017; Sneddon et al., 2018). In type I diabetic (T1D) 
patients, the autoimmune destruction of pancreatic beta-cells leads to insufficient 
production of insulin and hyperglycemia ensues (Pociot and Lernmark, 2016; Weir and 
Bonner-Weir, 2013). T2D is the most common form of the disease; it develops during 
adulthood and is characterized by β-cell dysfunction, insulin resistance and metabolic 
stress, which eventually lead to β-cell mass reduction (Nolan et al., 2011; Weir and 
Bonner-Weir, 2013). Despite the availability of insulin as treatment to temporarily restore 
the glucostasis in diabetic patients, this remedy is unable to avoid both the acute dangers 
of hypoglycemia or the long-term complications of hyperglycemia. Eventually, the 
challenge of treating diabetes centers on the replacement of the destroyed β-cells. Indeed, 
islet and whole pancreas transplantation have become gold-standard procedures in 
achieving glucose control in diabetic patients (Shapiro et al., 2000; Shapiro et al., 2017). 
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However, the extremely limited number of suitable donor tissues severely hampers the 
broad application of these therapies, underscoring the need for an unlimited source of 
insulin-producing cells that could be used in cell-based replacement therapy. 
Over the last decade, remarkable progress has been made with regard to the generation 
of functional β-cell equivalents from pluripotent stem cells (hES and iPS cells) and other 
cellular sources (Ellis et al., 2017; Sneddon et al., 2018). It has also become clear that the 
key to success is to closely recapitulate the path that pluripotent stem cells undertake 
during embryogenesis to become first definitive endoderm, then pancreatic progenitors, 
and finally pancreatic islet cells (Ellis et al., 2017; Sneddon et al., 2018). 
In a first landmark study by D’amour et al. (D'Amour et al., 2005), hESC cultures were 
differentiated into endoderm upon combined exposure to Wnt and Activin/TGFβ signalings 
and, subsequently, into endocrine progenitor cells following the activation of FGF10, RA 
and BMP inhibition, similar to what happens in the mouse embryo. This study has not only 
paved the way for making β-like cells in the lab, but also revealed that pancreatic signals, 
which create the micro-environment controlling β-cell development, are conserved 
between mouse and human (D'Amour et al., 2005). Subsequent studies have improved 
each step of this differentiation protocol, including the initial fate specification, maturation 
and proliferation (D'Amour et al., 2006; Kroon et al., 2008; Nostro et al., 2011; Pagliuca et 
al., 2014; Rezania et al., 2013; Russ et al., 2015). For example, compound screens of 
molecules have been performed to direct ES cells to the endodermal lineage and to induce 
pancreatic progenitor specification (Borowiak et al., 2009; Chen et al., 2009). Also, co-
culturing human and murine ESC-derived pancreatic and endocrine progenitors with 
primary pancreatic mesenchymal cell has been shown to promote progenitor expansion 
without altering differentiation potential (Sneddon et al., 2012). The same study 
subsequently tested the ability of sixteen growth factors to mimic the co-culture effect but 
none of them, alone or in combination, reproduced the co-culture effect at the same 
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magnitude, suggesting the involvement of cell-cell contact in this effect (Sneddon et al., 
2012). 
To date, the ex vivo generation of β-cell equivalents that possess physiological features of 
their native counterparts remains a challenge: hESC-derived insulin-producing cells often 
display features of immature β-cells and are frequently polyhormonal (Sneddon et al., 
2018). Nevertheless, once grafted in vivo in the mouse, these immature β-like cells are 
able to further differentiate and protect animals from chemical-induced diabetes (Kroon et 
al., 2008; Sneddon et al., 2018). More recent efforts have been placed on generating ex 
vivo single hormone-positive β-cells capable of glucose-stimulated insulin secretion and 
perfectly replicating all aspects of endogenous β-cells (Pagliuca et al., 2014; Rezania et 
al., 2013; Russ et al., 2015). 
Beside further refinement of the cytokine cocktail, recent studies have all underscored the 
benefits of three-dimensional cell culture system, which allows the generation of endocrine 
clusters that are perhaps closer to the endogenous islet (Pagliuca et al., 2014; Rezania et 
al., 2013; Russ et al., 2015). Indeed, a key determinant of β-cell function is cell-cell 
communication, among endocrine cells as well as with the cells in the islet niche, which is 
composed of multiple non-endocrine cell types, including endothelial, pericytes, neuronal, 
and mesenchymal cells (Aamodt and Powers, 2017; Brissova et al., 2014; Coronel and 
Stabler, 2013; Sasson et al., 2016). Given the specialized relationship between β-cells and 
supporting cells in their natural environment, future efforts are required to define elements 
of the endogenous β-cell niche for improving survival and function of hESC-derived β-cells 
in vitro. 
 
Open questions and future directions 
The interplay between pancreatic epithelium and all cellular components of the pancreatic 
microenvironment has been shown to be critical for the formation of a proper functional 
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pancreas. The understanding of the effectors and mechanisms underlying the crosstalk 
has tremendously helped in developing the current pancreatic differentiation protocols of 
pluripotent stem cells into β-cell equivalents for cell transplantation. Additionally, a 
comprehensive knowledge of the pancreatic microenvironment composition and its various 
signaling molecules will be relevant for further elucidating the pathogenesis underlying 
pancreatic diseases, such as cancer. PDAC is histologically characterized by an abundant 
stroma surrounding malignant epithelial cells that consists of a dynamic assortment of 
ECM components and fibroblasts, endothelial cells, immune cells, and neurons (Feig et 
al., 2012; Sinha and Leach, 2016). Accumulating evidence indicates that the epithelial and 
stromal compartments interact to enhance the aggressive nature of this disease (Feig et 
al., 2012; Sinha and Leach, 2016). Aberrant activation of embryonic signaling pathways is 
frequent in PDAC, making developmental regulators therapeutically attractive (Roy et al., 
2016). Specifically, a number of pathways, including Hedgehog, Notch and TGF-beta, 
which are at play in the pancreatic mesenchyme during development, are also involved in 
mediating cross-talk between the malignant pancreatic epithelium and its associated 
stroma, making them unique pathways to target for the treatment of pancreatic cancer 
(Bailey and Leach, 2012). How similar is the composition of the pancreatic 
microenvironment in the embryo and in the tumor is an open question that needs to be 
addressed. Only very recently, transcriptome analyses of human embryonic pancreatic 
mesenchyme have become available (Ramond et al., 2017), making such comparison 
possible. 
Many other questions deserve further investigation with regard to the pancreatic 
microenvironment in development and diseases. For instance, few examples of how 
mechanistically signaling pathways from the environment converge into the transcriptional 
cascade governing pancreatic development have been reported so far. Distinct types of 
interactions are likely to occur between different pancreatic cell types and surrounding 
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cells or ECM components, and these sets of interactions are dynamic and change with 
time. To date,  the information on the identity and spatial distribution of these different 
types of interaction is elusive. Also, the degree of heterogeneity within the pancreatic 
mesenchyme is a critical open question that starts only now to be unravelled (Byrnes et 
al., 2018). Single-cell transcriptome analysis suggests indeed the existence of different 
mesenchymal lineages creating distinct “cellular niches” (Byrnes et al., 2018). This 
heterogeneity and potential region-specific cross-talks are awaiting to be further 
characterized by lineage tracing and functional studies. Finally,  such information will 
enable the discovery of new paradigms on how fine-tuning the activity of different signaling 
pathways to achieve better differentiation and greater number of β-cell equivalents. 
 
 
 
  33 
REFERENCES 
Aamodt, K.I., Powers, A.C., 2017. Signals in the pancreatic islet microenvironment 
influence β-cell proliferation. Diabetes, Obesity and Metabolism 19, 124-136. 
Afelik, S., Pool, B., Schmerr, M., Penton, C., Jensen, J., 2015. Wnt7b is required for 
epithelial progenitor growth and operates during epithelial-to-mesenchymal signaling in 
pancreatic development. Developmental Biology 399, 204-217. 
Ahlgren, U., Pfaff, S.L., Jessell, T.M., Edlund, T., Edlund, H., 1997. Independent 
requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385, 
257-260. 
Ahnfelt-Rønne, J., Hald, J., Bødker, A., Yassin, H., Serup, P., Hecksher-Sørensen, J., 
2007. Preservation of proliferating pancreatic progenitor cells by Delta-Notch signaling in 
the embryonic chicken pancreas. BMC Developmental Biology 7, 63. 
Ahnfelt-Rønne, J., Jørgensen, M.C., Klinck, R., Jensen, J.N., Füchtbauer, E.-M., Deering, 
T., Macdonald, R.J., Wright, C.V.E., Madsen, O.D., Serup, P., 2012. Ptf1a-mediated 
control of Dll1 reveals an alternative to the lateral inhibition mechanism. Development 139, 
33–45. 
Ahnfelt-Rønne, J., Ravassard, P., Pardanaud-Glavieux, C., Scharfmann, R., Serup, P., 
2010. Mesenchymal Bone Morphogenetic Protein Signaling Is Required for Normal 
Pancreas Development. Diabetes 59, 1948-1956. 
Anderson, R.M., Delous, M., Bosch, J.A., Ye, L., Robertson, M.A., Hesselson, D., Stainier, 
D.Y.R., 2013. Hepatocyte Growth Factor Signaling in Intrapancreatic Ductal Cells Drives 
Pancreatic Morphogenesis. PLOS Genetics 9, e1003650. 
Angelo, J.R., Guerrero-Zayas, M.I., Tremblay, K.D., 2012. A fate map of the murine 
pancreas buds reveals a multipotent ventral foregut organ progenitor. PLoS ONE 7, 
e40707. 
  34 
Angelo, J.R., Tremblay, K.D., 2018. Identification and fate mapping of the pancreatic 
mesenchyme. Developmental Biology 435, 15-25. 
Apelqvist, A., Ahlgren, U., Edlund, H., 1997. Sonic hedgehog directs specialised 
mesoderm differentiation in the intestine and pancreas. Curr Biol 7, 801–804. 
Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., Angelis, M.H.d., 
Lendahl, U., Edlund, H., 1999. Notch signalling controls pancreatic cell differentiation. 
Nature 400, 877–881. 
Arda, H.E., Benitez, Cecil M., Kim, Seung K., 2013. Gene Regulatory Networks Governing 
Pancreas Development. Developmental Cell 25, 5-13. 
Arnaud-Dabernat, S., Kritzik, M., Kayali, A.G., Zhang, Y.-Q., Liu, G., Ungles, C., 
Sarvetnick, N., 2007. FGFR3 Is a Negative Regulator of the Expansion of Pancreatic 
Epithelial Cells. Diabetes 56, 96-106. 
Arregi, I., Climent, M., Iliev, D., Strasser, J., Gouignard, N., Johansson, J.K., Singh, T., 
Mazur, M., Semb, H., Artner, I., Minichiello, L., Pera, E.M., 2016. Retinol dehydrogenase-
10 regulates pancreas organogenesis and endocrine cell differentiation via paracrine 
retinoic acid signalling. Endocrinology, en.2016-1745. 
Asayesh, A., Sharpe, J., Watson, R.P., Hecksher-Sørensen, J., Hastie, N.D., Hill, R.E., 
Ahlgren, U., 2006. Spleen versus pancreas: strict control of organ interrelationship 
revealed by analyses of Bapx1−/− mice. Genes & Development 20, 2208-2213. 
Attali, M., Stetsyuk, V., Basmaciogullari, A., Aiello, V., Zanta-Boussif, M.A., Duvillie, B., 
Scharfmann, R., 2007. Control of β-Cell Differentiation by the Pancreatic Mesenchyme. 
Diabetes 56, 1248-1258. 
Azizoglu, D.B., Cleaver, O., 2016. Blood vessel crosstalk during organogenesis—focus on 
pancreas and endothelial cells. Wiley Interdisciplinary Reviews: Developmental Biology 5, 
598-617. 
  35 
Bailey, J.M., Leach, S.D., 2012. Signaling pathways mediating epithelial- mesenchymal 
crosstalk in pancreatic cancer: Hedgehog, Notch and TGFβ, in: Grippo, P.J., Munshi, H.G. 
(Eds.), Pancreatic Cancer and Tumor Microenvironment. Transworld Research Network, 
Trivandrum (India). 
Bankaitis, E.D., Bechard, M.E., Wright, C.V.E., 2015. Feedback control of growth, 
differentiation, and morphogenesis of pancreatic endocrine progenitors in an epithelial 
plexus niche. Genes & Development 29, 2203-2216. 
Bhushan, A., Itoh, N., Kato, S., Thiery, J.P., Czernichow, P., Bellusci, S., Scharfmann, R., 
2001. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor 
cells during early pancreatic organogenesis. Development 128, 5109-5117. 
Biankin, A.V., Waddell, N., Kassahn, K.S., Gingras, M.-C., Muthuswamy, L.B., Johns, A.L., 
Miller, D.K., Wilson, P.J., Patch, A.-M., Wu, J., Chang, D.K., Cowley, M.J., Gardiner, B.B., 
Song, S., Harliwong, I., Idrisoglu, S., Nourse, C., Nourbakhsh, E., Manning, S., Wani, S., 
Gongora, M., Pajic, M., Scarlett, C.J., Gill, A.J., Pinho, A.V., Rooman, I., Anderson, M., 
Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Nones, K., Fink, J.L., Christ, A., 
Bruxner, T., Cloonan, N., Kolle, G., Newell, F., Pinese, M., Mead, R.S., Humphris, J.L., 
Kaplan, W., Jones, M.D., Colvin, E.K., Nagrial, A.M., Humphrey, E.S., Chou, A., Chin, 
V.T., Chantrill, L.A., Mawson, A., Samra, J.S., Kench, J.G., Lovell, J.A., Daly, R.J., Merrett, 
N.D., Toon, C., Epari, K., Nguyen, N.Q., Barbour, A., Zeps, N., Kakkar, N., Zhao, F., Wu, 
Y.Q., Wang, M., Muzny, D.M., Fisher, W.E., Brunicardi, F.C., Hodges, S.E., Reid, J.G., 
Drummond, J., Chang, K., Han, Y., Lewis, L.R., Dinh, H., Buhay, C.J., Beck, T., Timms, L., 
Sam, M., Begley, K., Brown, A., Pai, D., Panchal, A., Buchner, N., De Borja, R., Denroche, 
R.E., Yung, C.K., Serra, S., Onetto, N., Mukhopadhyay, D., Tsao, M.-S., Shaw, P.A., 
Petersen, G.M., Gallinger, S., Hruban, R.H., Maitra, A., Iacobuzio-Donahue, C.A., 
Schulick, R.D., Wolfgang, C.L., Morgan, R.A., Lawlor, R.T., Capelli, P., Corbo, V., 
Scardoni, M., Tortora, G., Tempero, M.A., Mann, K.M., Jenkins, N.A., Perez-Mancera, 
  36 
P.A., Adams, D.J., Largaespada, D.A., Wessels, L.F.A., Rust, A.G., Stein, L.D., Tuveson, 
D.A., Copeland, N.G., Musgrove, E.A., Scarpa, A., Eshleman, J.R., Hudson, T.J., 
Sutherland, R.L., Wheeler, D.A., Pearson, J.V., McPherson, J.D., Gibbs, R.A., Grimmond, 
S.M., 2012. Pancreatic cancer genomes reveal aberrations in axon guidance pathway 
genes. Nature 491, 399-405. 
Byrnes, L.E, Wong D.M., Subramaniam M., Meyer N.P., Gilchrist C.L., Knox S.M., Tward 
A.D., Ye C.J., Sneddon J.B. 2018. Lineage dynamics of murine pancreatic development at 
single-cell resolution. Nature Communications  9, 3922. 
Borowiak, M., Maehr, R., Chen, S., Chen, A.E., Tang, W., Fox, J.L., Schreiber, S.L., 
Melton, D.A. 2009. Small Molecules Efficiently Direct Endodermal Differentiation of Mouse 
and Human Embryonic Stem Cells. Cell Stem Cell 4, 348-358. 
Bort, R., Martinez-Barbera, J.P., Beddington, R.S.P., Zaret, K.S. 2004. Hex homeobox 
gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. 
Development 131, 797-806. 
Brissova, M., Aamodt, K., Brahmachary, P., Prasad, N., Hong, J.-Y., Dai, C., Mellati, M., 
Shostak, A., Poffenberger, G., Aramandla, R., Levy, Shawn E., Powers, Alvin C., 2014. 
Islet Microenvironment, Modulated by Vascular Endothelial Growth Factor-A Signaling, 
Promotes β Cell Regeneration. Cell Metabolism 19, 498-511. 
Chen, S., Borowiak, M., Fox, J.L., Maehr, R., Osafune, K., Davidow, L., Lam, K., Peng, 
L.F., Schreiber, S.L., Rubin, L.L., Melton, D., 2009. A small molecule that directs 
differentiation of human ESCs into the pancreatic lineage. Nature Chemical Biology 5, 
258-265. 
Chen, Y., Pan, F.C., Brandes, N., Afelik, S., Sölter, M., Pieler, T., 2004. Retinoic acid 
signaling is essential for pancreas development and promotes endocrine at the expense of 
exocrine cell differentiation in Xenopus. Developmental Biology 271, 144-160. 
  37 
Chung, W.-S., Shin, C.H., Stainier, D.Y.R., 2008. Bmp2 Signaling Regulates the Hepatic 
versus Pancreatic Fate Decision. Developmental Cell 15, 738-748. 
Cirulli, V., Beattie, G.M., Klier, G., Ellisman, M., Ricordi, C., Quaranta, V., Frasier, F., Ishii, 
J.K., Hayek, A., Salomon, D.R., 2000. Expression and Function of αvβ3 and αvβ5 
Integrins in the Developing Pancreas. The Journal of Cell Biology 150, 1445-1460. 
Coronel, M.M., Stabler, C.L., 2013. Engineering a local microenvironment for pancreatic 
islet replacement. Current Opinion in Biotechnology 24, 900–908. 
Crane, G.M., Jeffery, E., Morrison, S.J., 2017. Adult haematopoietic stem cell niches. 
Nature Reviews Immunology 17, 573-590. 
Crisera, C.A., Kadison, A.S., Breslow, G.D., Maldonado, T.S., Longaker, M.T., Gittes, 
G.K., 2000. Expression and role of laminin-1 in mouse pancreatic organogenesis. 
Diabetes 49, 936-944. 
D'Amour, K.A., Agulnick, A.D., Eliazer, S., Kelly, O.G., Kroon, E., Baetge, E.E., 2005. 
Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature 
Biotechnology 23, 1534-1541. 
D'Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G., Moorman, 
M.A., Kroon, E., Carpenter, M.K., Baetge, E.E., 2006. Production of pancreatic hormone-
expressing endocrine cells from human embryonic stem cells. Nature Biotechnology 24, 
1392-1401. 
Dai, C., Huh, C.-G., Thorgeirsson, S.S., Liu, Y., 2005. β-Cell-Specific Ablation of the 
Hepatocyte Growth Factor Receptor Results in Reduced Islet Size, Impaired Insulin 
Secretion, and Glucose Intolerance. The American Journal of Pathology 167, 429-436. 
Demeterco, C., Beattie, G.M., Dib, S.A., Lopez, A.D., Hayek, A., 2000. A Role for Activin A 
and Betacellulin in Human Fetal Pancreatic Cell Differentiation and Growth. The Journal of 
Clinical Endocrinology & Metabolism 85, 3892-3897. 
  38 
Deutsch, G., Jung, J., Zheng, M., Lóra, J., Zaret, K.S., 2001. A bipotential precursor 
population for pancreas and liver within the embryonic endoderm. Development 128, 871–
881. 
Dichmann, D.S., Miller, C.P., Jensen, J., Heller, R.S., Serup, P., 2003. Expression and 
misexpression of members of the FGF and TGFbeta families of growth factors in the 
developing mouse pancreas. Dev Dyn 226, 663–674. 
Dong, P.D.S., Munson, C.A., Norton, W., Crosnier, C., Pan, X., Gong, Z., Neumann, C.J., 
Stainier, D.Y.R., 2007. Fgf10 regulates hepatopancreatic ductal system patterning and 
differentiation. Nature Genetics 39, 397-402. 
Drut, R.M., Drut, R., Gilbert-Barness, E., Reynolds, J.F., 1993. Abnormal spleen lobulation 
and short pancreas. Birth Defects Original Article Series 29, 345-352. 
Ellis, C., Ramzy, A., Kieffer, T.J., 2017. Regenerative medicine and cell-based approaches 
to restore pancreatic function. Nature Reviews Gastroenterology & Hepatology 14, 612-
628. 
Esni, F., Ghosh, B., Biankin, A.V., Lin, J.W., Albert, M.A., Yu, X., MacDonald, R.J., Civin, 
C.I., Real, F.X., Pack, M.A., Ball, D.W., Leach, S.D., 2004. Notch inhibits Ptf1 function and 
acinar cell differentiation in developing mouse and zebrafish pancreas. Development 131, 
4213-4224. 
Esni, F., Johansson, B.R., Radice, G.L., Semb, H., 2001. Dorsal pancreas agenesis in N-
cadherin- deficient mice. Dev Biol 238, 202–212. 
Feig, C., Gopinathan, A., Neesse, A., Chan, D.S., Cook, N., Tuveson, D.A., 2012. The 
pancreas cancer microenvironment. Clinical cancer research : an official journal of the 
American Association for Cancer Research 18, 4266-4276. 
Gao, T., McKenna, B., Li, C., Reichert, M., Nguyen, J., Singh, T., Yang, C., Pannikar, A., 
Doliba, N., Zhang, T., Stoffers, Doris A., Edlund, H., Matschinsky, F., Stein, R., Stanger, 
  39 
Ben Z., 2014. Pdx1 Maintains β Cell Identity and Function by Repressing an α Cell 
Program. Cell Metabolism 19, 259-271. 
Garcia-Ocaña, A., Takane, K.K., Syed, M.A., Philbrick, W.M., Vasavada, R.C., Stewart, 
A.F., 2000. Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice 
Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia. 
Journal of Biological Chemistry 275, 1226-1232. 
Georgia, S., Soliz, R., Li, M., Zhang, P., Bhushan, A., 2006. p57 and Hes1 coordinate cell 
cycle exit with self-renewal of pancreatic progenitors. Developmental Biology 298, 22-31. 
Gittes, G.K., 2009. Developmental biology of the pancreas: a comprehensive review. 
Developmental Biology 326, 4–35. 
Glentis, A., Gurchenkov, V., Vignjevic, D.M., 2014. Assembly, heterogeneity, and 
breaching of the basement membranes. Cell Adhesion & Migration 8, 236-245. 
Golosow, N., Grobstein, C., 1962. Epitheliomesenchymal interaction in pancreatic 
morphogenesis. Dev Biol 4, 242–255. 
Goulley, J., Dahl, U., Baeza, N., Mishina, Y., Edlund, H., 2007. BMP4-BMPR1A Signaling 
in β Cells Is Required for and Augments Glucose-Stimulated Insulin Secretion. Cell 
Metabolism 5, 207-219. 
Gouzi, M., Kim, Y.H., Katsumoto, K., Johansson, K., Grapin-Botton, A., 2011. Neurogenin3 
initiates stepwise delamination of differentiating endocrine cells during pancreas 
development. Developmental Dynamics 240, 589-604. 
Gualdi, R., Bossard, P., Zheng, M., Hamada, Y., Coleman, J.R., Zaret, K.S., 1996. Hepatic 
specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes 
& Development 10, 1670-1682. 
Guo, W., Giancotti, F.G., 2004. Integrin signalling during tumour progression. Nature 
Reviews Molecular Cell Biology 5, nrm1490. 
  40 
Hadar, H., Gadoth, N., Herskovitz, P., Heifetz, M., 1991. Short pancreas in polysplenia 
syndrome. Acta Radiologica (Stockholm, Sweden: 1987) 32, 299-301. 
Hart, A., Papadopoulou, S., Edlund, H., 2003. Fgf10 maintains notch activation, stimulates 
proliferation, and blocks differentiation of pancreatic epithelial cells. Dev Dyn 228, 185–
193. 
Haumaitre, C., Barbacci, E., Jenny, M., Ott, M.O., Gradwohl, G., Cereghini, S., 2005. Lack 
of TCF2/vHNF1 in mice leads to pancreas agenesis. Proceedings of the National 
Academy of Sciences 102, 1490-1495. 
Hebrok, M., Kim, S.K., Jacques, B.S., McMahon, A.P., Melton, D.A., 2000. Regulation of 
pancreas development by hedgehog signaling. Development 127, 4905–4913. 
Hebrok, M., Kim, S.K., Melton, D.A., 1998. Notochord repression of endodermal Sonic 
hedgehog permits pancreas development. Genes & Development 12, 1705-1713. 
Hecksher-Sørensen, J., Watson, R.P., Lettice, L.A., Serup, P., Eley, L., Angelis, C.D., 
Ahlgren, U., Hill, R.E., 2004. The splanchnic mesodermal plate directs spleen and 
pancreatic laterality, and is regulated by Bapx1/Nkx3.2. Development 131, 4665-4675. 
Heiser, P.W., Lau, J., Taketo, M.M., Herrera, P.L., Hebrok, M., 2006. Stabilization of beta-
catenin impacts pancreas growth. Development 133, 2023–2032. 
Heller, R.S., Dichmann, D.S., Jensen, J., Miller, C., Wong, G., Madsen, O.D., Serup, P., 
2002. Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic 
mice suggesting a role for Wnts in pancreas and foregut pattern formation. Dev Dyn 225, 
260–270. 
Henseleit, K.D., Nelson, S.B., Kuhlbrodt, K., Hennings, J.C., Ericson, J., Sander, M., 2005. 
NKX6 transcription factor activity is required for alpha- and beta-cell development in the 
pancreas. Development 132, 3139–3149. 
Herman, T.E., Siegel, M.J., 1991. Polysplenia syndrome with congenital short pancreas. 
American Journal of Roentgenology 156, 799-800. 
  41 
Hibsher, D., Epshtein, A., Oren, N., Landsman, L., 2016. Pancreatic Mesenchyme 
Regulates Islet Cellular Composition in a Patched/Hedgehog-Dependent Manner. 
Scientific Reports 6, 38008. 
Hick, A., van Eyll, J., Cordi, S., Forez, C., Passante, L., Kohara, H., Nagasawa, T., 
Vanderhaeghen, P., Courtoy, P., Rousseau, G., Lemaigre, F., Pierreux, C., 2009. 
Mechanism of  primitive duct formation in the pancreas and submandibular glands: a role 
for SDF-1. BMC Dev Biol. 9, 66. 
Hisaoka, M., Haratake, J., Hashimoto, H., 1993. Pancreatic morphogenesis and 
extracellular matrix organization during rat development. Differentiation; Research in 
Biological Diversity 53, 163-172. 
Hogan, B.L.M., 1999. Morphogenesis. Cell 96, 225-233. 
Huotari, M.-A., Miettinen, P.J., Palgi, J., Koivisto, T., Ustinov, J., Harari, D., Yarden, Y., 
Otonkoski, T., 2002. ErbB Signaling Regulates Lineage Determination of Developing 
Pancreatic Islet Cells in Embryonic Organ Culture. Endocrinology 143, 4437-4446. 
Jacquemin, P., Yoshitomi, H., Kashima, Y., Rousseau, G.G., Lemaigre, F.P., Zaret, K.S., 
2006. An endothelial–mesenchymal relay pathway regulates early phases of pancreas 
development. Developmental Biology 290, 189-199. 
Jensen, J., Pedersen, E.E., Galante, P., Hald, J., Heller, R.S., Ishibashi, M., Kageyama, 
R., Guillemot, F., Serup, P., Madsen, O.D., 2000. Control of endodermal endocrine 
development by Hes-1. Nat Genet 24, 36–44. 
Jiang, F.X., Cram, D.S., DeAizpurua, H.J., Harrison, L.C., 1999. Laminin-1 promotes 
differentiation of fetal mouse pancreatic beta-cells. Diabetes 48, 722-730. 
Jiang, F.X., Georges-Labouesse, E., Harrison, L.C., 2001. Regulation of laminin 1-induced 
pancreatic beta-cell differentiation by alpha6 integrin and alpha-dystroglycan. Molecular 
Medicine 7, 107-114. 
  42 
Jørgensen, M.C., Ahnfelt-Rønne, J., Hald, J., Madsen, O.D., Serup, P., Hecksher-
Sørensen, J., 2006. An Illustrated Review of Early Pancreas Development in the Mouse. 
Endocrine Reviews 28, 685-705. 
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R.J., Wright, C.V.E., 2002. 
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic 
progenitors. Nature Genetics 32, 128-134. 
Kawahira, H., Ma, N.H., Tzanakakis, E.S., McMahon, A.P., Chuang, P.-T., Hebrok, M., 
2003. Combined activities of hedgehog signaling inhibitors regulate pancreas 
development. Development 130, 4871-4879. 
Kawahira, H., Scheel, D.W., Smith, S.B., German, M.S., Hebrok, M., 2005. Hedgehog 
signaling regulates expansion of pancreatic epithelial cells. Developmental Biology 280, 
111-121. 
Kesavan, G., Sand, F.W., Greiner, T.U., Johansson, J.K., Kobberup, S., Wu, X., 
Brakebusch, C., Semb, H., 2009. Cdc42-Mediated Tubulogenesis Controls Cell 
Specification. Cell 139, 791-801. 
Kfoury, Y., Scadden, David T., 2015. Mesenchymal Cell Contributions to the Stem Cell 
Niche. Cell Stem Cell 16, 239-253. 
Kim, S.K., Hebrok, M., Li, E., Oh, S.P., Schrewe, H., Harmon, E.B., Lee, J.S., Melton, 
D.A., 2000. Activin receptor patterning of foregut organogenesis. Genes & Development 
14, 1866–1871. 
Kim, S.K., Hebrok, M., Melton, D.A., 1997. Notochord to endoderm signaling is required for 
pancreas development. Development 124, 4243-4252. 
Kim, S.W., Shin, H.C., Kim, I.Y., Bae, S.-B., Park, J.M., 2009. Duplication of the spleen 
with a short pancreas. The British Journal of Radiology 82, e42-e43. 
Koss, M., Bolze, A., Brendolan, A., Saggese, M., Capellini, Terence D., Bojilova, E., 
Boisson, B., Prall, Owen W.J., Elliott, D.A., Solloway, M., Lenti, E., Hidaka, C., Chang, C.-
  43 
P., Mahlaoui, N., Harvey, Richard P., Casanova, J.-L., Selleri, L., 2012. Congenital 
Asplenia in Mice and Humans with Mutations in a Pbx/Nkx2-5/p15 Module. Developmental 
Cell 22, 913-926. 
Kritzik, M.R., Krahl, T., Good, A., Gu, D., Lai, C., Fox, H., Sarvetnick, N., 2000. Expression 
of ErbB receptors during pancreatic islet development and regrowth. Journal of 
Endocrinology 165, 67-77. 
Kroon, E., Martinson, L.A., Kadoya, K., Bang, A.G., Kelly, O.G., Eliazer, S., Young, H., 
Richardson, M., Smart, N.G., Cunningham, J., Agulnick, A.D., D'Amour, K.A., Carpenter, 
M.K., Baetge, E.E., 2008. Pancreatic endoderm derived from human embryonic stem cells 
generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology 26, 
443-452. 
Kumar, M., Jordan, N., Melton, D., Grapin-Botton, A., 2003. Signals from lateral plate 
mesoderm instruct endoderm toward a pancreatic fate. Developmental Biology 259, 109-
122. 
Lammert, E., Brown, J., Melton, D.A., 2000. Notch gene expression during pancreatic 
organogenesis. Mechanisms of Development 94, 199–203. 
Lammert, E., Cleaver, O., Melton, D., 2001. Induction of Pancreatic Differentiation by 
Signals from Blood Vessels. Science 294, 564-567. 
Landsman, L., Nijagal, A., Whitchurch, T.J., VanderLaan, R.L., Zimmer, W.E., MacKenzie, 
T.C., Hebrok, M., 2011. Pancreatic Mesenchyme Regulates Epithelial Organogenesis 
throughout Development. PLOS Biol 9, e1001143. 
Larsen, B.M., Hrycaj, S.M., Newman, M., Li, Y., Wellik, D.M., 2015. Mesenchymal Hox6 
function is required for mouse pancreatic endocrine cell differentiation. Development 142, 
3859-3868. 
Larsen, H.L., Grapin-Botton, A., 2017. The molecular and morphogenetic basis of 
pancreas organogenesis. Seminars in Cell & Developmental Biology 66, 51-68. 
  44 
Lattanzi, W., Parolisi, R., Barba, M., Bonfanti, L., 2015. Osteogenic and Neurogenic Stem 
Cells in Their Own Place: Unraveling Differences and Similarities Between Niches. 
Frontiers in Cellular Neuroscience 9. 
Lee, J.-H., Tammela, T., Hofree, M., Choi, J., Marjanovic, N.D., Han, S., Canner, D., Wu, 
K., Paschini, M., Bhang, D.H., Jacks, T., Regev, A., Kim, C.F., 2017. Anatomically and 
Functionally Distinct Lung Mesenchymal Populations Marked by Lgr5 and Lgr6. Cell 170, 
1149-1163.e1112. 
Li, L.-C., Qiu, W.-L., Zhang, Y.-W., Xu, Z.-R., Xiao, Y.-N., Hou, C., Lamaoqiezhong, Yu, P., 
Cheng, X., Xu, C.-R., 2018. Single-cell transcriptomic analyses reveal distinct 
dorsal/ventral pancreatic programs. EMBO reports, e46148. 
Li, Y., Rankin, S.A., Sinner, D., Kenny, A.P., Krieg, P.A., Zorn, A.M., 2008. Sfrp5 
coordinates foregut specification and morphogenesis by antagonizing both canonical and 
noncanonical Wnt11 signaling. Genes & Development 22, 3050-3063. 
Löf-Öhlin, Z.M., Nyeng, P., Bechard, M.E., Hess, K., Bankaitis, E., Greiner, T.U., Ameri, J., 
Wright, C.V., Semb, H., 2017. EGFR signalling controls cellular fate and pancreatic 
organogenesis by regulating apicobasal polarity. Nature Cell Biology 19, 1313-1325. 
Low, J.P., Williams, D., Chaganti, J.R., 2011. Polysplenia syndrome with agenesis of the 
dorsal pancreas and preduodenal portal vein presenting with obstructive jaundice—a case 
report and literature review. The British Journal of Radiology 84, e219-e222. 
Magenheim, J., Ilovich, O., Lazarus, A., Klochendler, A., Ziv, O., Werman, R., Hija, A., 
Cleaver, O., Mishani, E., Keshet, E., Dor, Y., 2011a. Blood vessels restrain pancreas 
branching, differentiation and growth. Development 138, 4743–4752. 
Magenheim, J., Klein, A.M., Stanger, B.Z., Ashery-Padan, R., Sosa-Pineda, B., Gu, G., 
Dor, Y., 2011b. Ngn3+ endocrine progenitor cells control the fate and morphogenesis of 
pancreatic ductal epithelium. Developmental Biology 359, 26-36. 
  45 
Maldonado, T.S., Kadison, A.S., Crisera, C.A., Grau, J.B., Alkasab, S.L., Longaker, M.T., 
Gittes, G.K., 2000. Ontogeny of activin B and follistatin in developing embryonic mouse 
pancreas: implications for lineage selection. Journal of Gastrointestinal Surgery: Official 
Journal of the Society for Surgery of the Alimentary Tract 4, 269-275. 
Manfroid, I., Delporte, F., Baudhuin, A., Motte, P., Neumann, C.J., Voz, M.L., Martial, J.A., 
Peers, B., 2007. Reciprocal endoderm-mesoderm interactions mediated by fgf24 and fgf10 
govern pancreas development. Development 134, 4011-4021. 
Martín, M., Gallego-Llamas, J., Ribes, V., Kedinger, M., Niederreither, K., Chambon, P., 
Dollé, P., Gradwohl, G., 2005. Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 
mutant mice. Developmental Biology 284, 399-411. 
Massagué, J., Seoane, J., Wotton, D., 2005. Smad transcription factors. Genes & 
Development 19, 2783-2810. 
Mastracci, T.L., Anderson, K.R., Papizan, J.B., Sussel, L., 2013. Regulation of Neurod1 
contributes to the lineage potential of Neurogenin3+ endocrine precursor cells in the 
pancreas. PLoS Genet 9, e1003278. 
McLin, V.A., Rankin, S.A., Zorn, A.M., 2007. Repression of Wnt/β-catenin signaling in the 
anterior endoderm is essential for liver and pancreas development. Development 134, 
2207-2217. 
Mfopou, J.K., Chen, B., Mateizel, I., Sermon, K., Bouwens, L., 2010. Noggin, Retinoids, 
and Fibroblast Growth Factor Regulate Hepatic or Pancreatic Fate of Human Embryonic 
Stem Cells. Gastroenterology 138, 2233-2245.e2214. 
Miettinen, P.J., Huotari, M., Koivisto, T., Ustinov, J., Palgi, J., Rasilainen, S., Lehtonen, E., 
Keski-Oja, J., Otonkoski, T., 2000. Impaired migration and delayed differentiation of 
pancreatic islet cells in mice lacking EGF-receptors. Development 127, 2617–2627. 
Miettinen, P.J., Ustinov, J., Ormio, P., Gao, R., Palgi, J., Hakonen, E., Juntti-Berggren, L., 
Berggren, P.-O., Otonkoski, T., 2006. Downregulation of EGF Receptor Signaling in 
  46 
Pancreatic Islets Causes Diabetes Due to Impaired Postnatal β-Cell Growth. Diabetes 55, 
3299-3308. 
Miralles, F., Battelino, T., Czernichow, P., Scharfmann, R., 1998a. TGF-beta plays a key 
role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of 
the matrix metalloproteinase MMP-2. The Journal of Cell Biology 143, 827–836. 
Miralles, F., Czernichow, P., Ozaki, K., Itoh, N., Scharfmann, R., 1999. Signaling through 
fibroblast growth factor receptor 2b plays a key role in the development of the exocrine 
pancreas. Proc Natl Acad Sci USA 96, 6267–6272. 
Miralles, F., Czernichow, P., Scharfmann, R., 1998b. Follistatin regulates the relative 
proportions of endocrine versus exocrine tissue during pancreatic development. 
Development 125, 1017–1024. 
Miralles, F., Lamotte, L., Couton, D., Joshi, R.L., 2006. Interplay between FGF10 and 
Notch signalling is required for the self-renewal of pancreatic progenitors. Int J Dev Biol 
50, 17–26. 
Miyatsuka, T., Kosaka, Y., Kim, H., German, M.S., 2011. Neurogenin3 inhibits proliferation 
in endocrine progenitors by inducing Cdkn1a. Proceedings of the National Academy of 
Sciences 108, 185-190. 
Molotkov, A., Molotkova, N., Duester, G., 2005. Retinoic acid generated by Raldh2 in 
mesoderm is required for mouse dorsal endodermal pancreas development. Dev Dyn 232, 
950–957. 
Muñoz-Bravo, J.L., Hidalgo-Figueroa, M., Pascual, A., López-Barneo, J., Leal-Cerro, A., 
Cano, D.A., 2013. GDNF is required for neural colonization of the pancreas. Development 
140, 3669-3679. 
Murtaugh, L.C., Law, A.C., Dor, Y., Melton, D.A., 2005. Beta-catenin is essential for 
pancreatic acinar but not islet development. Development 132, 4663–4674. 
  47 
Murtaugh, L.C., Stanger, B.Z., Kwan, K.M., Melton, D.A., 2003. Notch signaling controls 
multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA 100, 14920–14925. 
Nekrep, N., Wang, J., Miyatsuka, T., German, M.S., 2008. Signals from the neural crest 
regulate beta-cell mass in the pancreas. Development 135, 2151–2160. 
Nolan, C.J., Damm, P., Prentki, M., 2011. Type 2 diabetes across generations: from 
pathophysiology to prevention and management. The Lancet 378, 169-181. 
Norgaard, G.A., Jensen, J.N., Jensen, J., 2003. FGF10 signaling maintains the pancreatic 
progenitor cell state revealing a novel role of Notch in organ development. Developmental 
Biology 264, 323–338. 
Nostro, M.C., Sarangi, F., Ogawa, S., Holtzinger, A., Corneo, B., Li, X., Micallef, S.J., Park, 
I.-H., Basford, C., Wheeler, M.B., Daley, G.Q., Elefanty, A.G., Stanley, E.G., Keller, G., 
2011. Stage-specific signaling through TGFβ family members and WNT regulates 
patterning and pancreatic specification of human pluripotent stem cells. Development 138, 
861-871. 
Ober, E.A., Verkade, H., Field, H.A., Stainier, D.Y.R., 2006. Mesodermal Wnt2b signalling 
positively regulates liver specification. Nature 442, 688-691. 
Offield, M.F., Jetton, T.L., Labosky, P.A., Ray, M., Stein, R.W., Magnuson, M.A., Hogan, 
B.L., Wright, C.V., 1996. PDX-1 is required for pancreatic outgrowth and differentiation of 
the rostral duodenum. Development 122, 983-995. 
Osipovich, A.B., Long, Q., Manduchi, E., Gangula, R., Hipkens, S.B., Schneider, J., 
Okubo, T., Stoeckert, C.J., Takada, S., Magnuson, M.A., 2014. Insm1 promotes endocrine 
cell differentiation by modulating the expression of a network of genes that includes 
Neurog3 and Ripply3. Development 141, 2939–2949. 
Otonkoski, T., Cirulli, V., Beattie, M., Mally, M.I., Soto, G., Rubin, J.S., Hayek, A., 1996. A 
role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic 
beta-cell growth. Endocrinology 137, 3131-3139. 
  48 
Pagliuca, Felicia W., Millman, Jeffrey R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, 
Jennifer H., Peterson, Quinn P., Greiner, D., Melton, Douglas A., 2014. Generation of 
Functional Human Pancreatic β Cells In Vitro. Cell 159, 428-439. 
Pan, F.C., Wright, C., 2011. Pancreas organogenesis: From bud to plexus to gland. 
Developmental Dynamics 240, 530-565. 
Papadopoulou, S., Edlund, H., 2005. Attenuated Wnt Signaling Perturbs Pancreatic 
Growth but Not Pancreatic Function. Diabetes 54, 2844-2851. 
Petzold, K.M., Naumann, H., Spagnoli, F.M., 2013. Rho signalling restriction by the 
RhoGAP Stard13 integrates growth and morphogenesis in the pancreas. Development 
140, 126-135. 
Pierreux, C.E., Cordi, S., Hick, A.-C., Achouri, Y., Ruiz de Almodovar, C., Prévot, P.-P., 
Courtoy, P.J., Carmeliet, P., Lemaigre, F.P., 2010. Epithelial: Endothelial cross-talk 
regulates exocrine differentiation in developing pancreas. Developmental Biology 347, 
216-227. 
Plank, J.L., Mundell, N.A., Frist, A.Y., Legrone, A.W., Kim, T., Musser, M.A., Walter, T.J., 
Labosky, P.A., 2011. Influence and timing of arrival of murine neural crest on pancreatic 
beta cell development and maturation. Developmental Biology 349, 321–330. 
Pociot, F., Lernmark, Å., 2016. Genetic risk factors for type 1 diabetes. The Lancet 387, 
2331-2339. 
Pulkkinen, M.-A., Spencer-Dene, B., Dickson, C., Otonkoski, T., 2003. The IIIb isoform of 
fibroblast growth factor receptor 2 is required for proper growth and branching of 
pancreatic ductal epithelium but not for differentiation of exocrine or endocrine cells. 
Mechanisms of Development 120, 167-175. 
Puri, S., Hebrok, M., 2007. Dynamics of embryonic pancreas development using real-time 
imaging. Developmental Biology 306, 82-93. 
  49 
Qu, X., Afelik, S., Jensen, J.N., Bukys, M.A., Kobberup, S., Schmerr, M., Xiao, F., Nyeng, 
P., Albertoni, M.V., Grapin-Botton, A., Jensen, J., 2013. Notch-mediated post-translational 
control of Ngn3 protein stability regulates pancreatic patterning and cell fate commitment. 
Developmental Biology 376, 1–12. 
Ramond, C., Glaser, N., Berthault, C., Ameri, J., Kirkegaard, J.S., Hansson, M., Honoré, 
C., Semb, H., Scharfmann, R., 2017. Reconstructing human pancreatic differentiation by 
mapping specific cell populations during development. eLife 6, e27564. 
Rezania, A., Bruin, J.E., Xu, J., Narayan, K., Fox, J.K., O'Neil, J.J., Kieffer, T.J., 2013. 
Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic 
progenitor cells accelerates the maturation of insulin-secreting cells in vivo. STEM CELLS 
31, 2432-2442. 
Ritvos, O., Tuuri, T., Erämaa, M., Sainio, K., Hildén, K., Saxén, L., Gilbert, S.F., 1995. 
Activin disrupts epithelial branching morphogenesis in developing glandular organs of the 
mouse. Mechanisms of Development 50, 229-245. 
Roberts, K.J., Kershner, A.M., Beachy, P.A., 2017. The Stromal Niche for Epithelial Stem 
Cells: A Template for Regeneration and a Brake on Malignancy. Cancer Cell 32, 404-410. 
Roccisana, J., Reddy, V., Vasavada, R.C., Gonzalez-Pertusa, J.A., Magnuson, M.A., 
Garcia-Ocaña, A., 2005. Targeted Inactivation of Hepatocyte Growth Factor Receptor c-
met in β-Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without 
Alteration of β-Cell Mass. Diabetes 54, 2090-2102. 
Rodríguez-Seguel, E., Mah, N., Naumann, H., Pongrac, I.M., Cerdá-Esteban, N., Fontaine, 
J.-F., Wang, Y., Chen, W., Andrade-Navarro, M.A., Spagnoli, F.M., 2013. Mutually 
exclusive signaling signatures define the hepatic and pancreatic progenitor cell lineage 
divergence. Genes & Development 27, 1932–1946. 
Romer, A.I., Sussel, L., 2015. Pancreatic islet cell development and regeneration. Current 
Opinion in Endocrinology, Diabetes and Obesity 22, 255. 
  50 
Rossi, J.M., Dunn, N.R., Hogan, B.L.M., Zaret, K.S., 2001. Distinct mesodermal signals, 
including BMPs from the septum transversum mesenchyme, are required in combination 
for hepatogenesis from the endoderm. Genes & Development 15, 1998-2009. 
Roy, N., Takeuchi, K.K., Ruggeri, J.M., Bailey, P., Chang, D., Li, J., Leonhardt, L., Puri, S., 
Hoffman, M.T., Gao, S., Halbrook, C.J., Song, Y., Ljungman, M., Malik, S., Wright, C.V.E., 
Dawson, D.W., Biankin, A.V., Hebrok, M., Crawford, H.C., 2016. PDX1 dynamically 
regulates pancreatic ductal adenocarcinoma initiation and maintenance. Genes & 
Development 30, 2669-2683. 
Russ, H.A., Parent, A.V., Ringler, J.J., Hennings, T.G., Nair, G.G., Shveygert, M., Guo, T., 
Puri, S., Haataja, L., Cirulli, V., Blelloch, R., Szot, G.L., Arvan, P., Hebrok, M., 2015. 
Controlled induction of human pancreatic progenitors produces functional beta-like cells in 
vitro. The EMBO Journal, 1–15. 
Sand, F.W., Hörnblad, A., Johansson, J.K., Lorén, C., Edsbagge, J., Ståhlberg, A., 
Magenheim, J., Ilovich, O., Mishani, E., Dor, Y., Ahlgren, U., Semb, H., 2011. Growth-
limiting role of endothelial cells in endoderm development. Developmental Biology 352, 
267-277. 
Sander, M., Sussel, L., Conners, J., Scheel, D., Kalamaras, J., Cruz, F.D., Schwitzgebel, 
V., Hayes-Jordan, A., German, M., 2000. Homeobox gene Nkx6.1 lies downstream of 
Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127, 
5533–5540. 
Sanvito, F., Nichols, A., Herrera, P.L., Huarte, J., Wohlwend, A., Vassalli, J.D., Orci, L., 
1995. TGF-β1 Overexpression in Murine Pancreas Induces Chronic Pancreatitis and 
Together with TNF-α, Triggers Insulin-Dependent Diabetes. Biochemical and Biophysical 
Research Communications 217, 1279-1286. 
Sasson, A., Rachi, E., Sakhneny, L., Baer, D., Lisnyansky, M., Epshtein, A., Landsman, L., 
2016. Islet Pericytes Are Required for β-Cell Maturity. Diabetes 65, 3008-3014. 
  51 
Sener, R.N., Alper, H., 1994. Polysplenia syndrome: a case associated with transhepatic 
portal vein, short pancreas, and left inferior vena cava with hemiazygous continuation. 
Abdominal Imaging 19, 64-66. 
Seymour, P.A., Freude, K.K., Tran, M.N., Mayes, E.E., Jensen, J., Kist, R., Scherer, G., 
Sander, M., 2007. SOX9 is required for maintenance of the pancreatic progenitor cell pool. 
Proceedings of the National Academy of Sciences 104, 1865-1870. 
Seymour, P.A., Shih, H.P., Patel, N.A., Freude, K.K., Xie, R., Lim, C.J., Sander, M., 2012. 
A Sox9/Fgf feed-forward loop maintains pancreatic organ identity. Development 139, 
3363-3372. 
Shapiro, A.M.J., Lakey, J.R.T., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., 
Kneteman, N.M., Rajotte, R.V., 2000. Islet Transplantation in Seven Patients with Type 1 
Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen. New 
England Journal of Medicine 343, 230-238. 
Shapiro, A.M.J., Pokrywczynska, M., Ricordi, C., 2017. Clinical pancreatic islet 
transplantation. Nature Reviews Endocrinology 13, 268-277. 
Shen, C.-N., Marguerie, A., Chien, C.-Y., Dickson, C., Slack, J.M.W., Tosh, D., 2007. All-
trans retinoic acid suppresses exocrine differentiation and branching morphogenesis in the 
embryonic pancreas. Differentiation 75, 62-74. 
Shih, H.P., Panlasigui, D., Cirulli, V., Sander, M., 2016. ECM Signaling Regulates 
Collective Cellular Dynamics to Control Pancreas Branching Morphogenesis. Cell Rep 14, 
169–179. 
Shih, H.P., Wang, A., Sander, M., 2013. Pancreas Organogenesis: From Lineage 
Determination to Morphogenesis. Annual Review of Cell and Developmental Biology 29, 
81-105. 
Sinha, S., Leach, S.D., 2016. New insights in the development of pancreatic cancer. 
Current Opinion in Gastroenterology 32, 394. 
  52 
Slack, J.M., 1995. Developmental biology of the pancreas. Development 121, 1569-1580. 
Sneddon, J.B., Borowiak, M., Melton, D.A., 2012. Self-renewal of embryonic-stem-cell-
derived progenitors by organ-matched mesenchyme. Nature 491, 765-768. 
Sneddon, J.B., Tang, Q., Stock, P., Bluestone, J.A., Roy, S., Desai, T., Hebrok, M., 2018. 
Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges. Cell 
Stem Cell 22, 810-823. 
Solar, M., Cardalda, C., Houbracken, I., Martín, M., Maestro, M.A., De Medts, N., Xu, X., 
Grau, V., Heimberg, H., Bouwens, L., Ferrer, J., 2009. Pancreatic Exocrine Duct Cells 
Give Rise to Insulin-Producing β Cells during Embryogenesis but Not after Birth. 
Developmental Cell 17, 849-860. 
Spagnoli, F.M., 2007. From endoderm to pancreas: a multistep journey. Cellular and 
Molecular Life Sciences 64, 2378-2390. 
Spagnoli, F.M., Brivanlou, A.H., 2008. The Gata5 target, TGIF2, defines the pancreatic 
region by modulating BMP signals within the endoderm. Development 135, 451-461. 
Sriplung, H., 1991. Polysplenia syndrome: a case with congenital heart block, infarction of 
a splenic mass, and a short pancreas. Journal of the Medical Association of Thailand = 
Chotmaihet Thangphaet 74, 355-358. 
Stafford, D., Prince, V.E., 2002. Retinoic Acid Signaling Is Required for a Critical Early 
Step in Zebrafish Pancreatic Development. Current Biology 12, 1215-1220. 
Taylor, B.L., Liu, F.-F., Sander, M., 2013. Nkx6.1 Is Essential for Maintaining the 
Functional State of Pancreatic Beta Cells. Cell Reports 4, 1262-1275. 
Thomas, M.K., Lee, J.H., Rastalsky, N., Habener, J.F., 2001. Hedgehog Signaling 
Regulation of Homeodomain Protein Islet Duodenum Homeobox-1 Expression in 
Pancreatic β-Cells. Endocrinology 142, 1033-1040. 
Thomas, M.K., Rastalsky, N., Lee, J.H., Habener, J.F., 2000. Hedgehog signaling 
regulation of insulin production by pancreatic beta-cells. Diabetes 49, 2039-2047. 
  53 
Tremblay, K.D., Zaret, K.S., 2005. Distinct populations of endoderm cells converge to 
generate the embryonic liver bud and ventral foregut tissues. Dev Biol 280, 87–99. 
Tulachan, S.S., Doi, R., Kawaguchi, Y., Tsuji, S., Nakajima, S., Masui, T., Koizumi, M., 
Toyoda, E., Mori, T., Ito, D., Kami, K., Fujimoto, K., Imamura, M., 2003. All-Trans Retinoic 
Acid Induces Differentiation of Ducts and Endocrine Cells by Mesenchymal/Epithelial 
Interactions in Embryonic Pancreas. Diabetes 52, 76-84. 
Tulachan, S.S., Tei, E., Hembree, M., Crisera, C., Prasadan, K., Koizumi, M., Shah, S., 
Guo, P., Bottinger, E., Gittes, G.K., 2007. TGF-beta isoform signaling regulates secondary 
transition and mesenchymal-induced endocrine development in the embryonic mouse 
pancreas. Dev Biol 305, 508–521. 
Verschueren, K., Dewulf, N., Goumans, M.-J., Lonnoy, O., Feijen, A., Grimsby, S., Vande 
Spiegle, K., ten Dijke, P., Moren, A., Vanscheeuwijck, P., Heldin, C.-H., Miyazono, K., 
Mummery, C., Van Den Eijnden-Van Raaij, J., Huylebroeck, D., 1995. Expression of type I 
and type IB receptors for activin in midgestation mouse embryos suggests distinct 
functions in organogenesis. Mechanisms of Development 52, 109-123. 
Villasenor, A., Marty-Santos, L., Dravis, C., Fletcher, P., Henkemeyer, M., Cleaver, O., 
2012. EphB3 marks delaminating endocrine progenitor cells in the developing pancreas. 
Developmental Dynamics 241, 1008-1019. 
Wainwright, H., Nelson, M., 1993. Polysplenia syndrome and congenital short pancreas. 
American Journal of Medical Genetics 47, 318-320. 
Wandzioch, E., Zaret, K.S., 2009. Dynamic signaling network for the specification of 
embryonic pancreas and liver progenitors. Science 324, 1707–1710. 
Weir, G.C., Bonner-Weir, S., 2013. Islet β cell mass in diabetes and how it relates to 
function, birth, and death. Annals of the New York Academy of Sciences 1281, 92-105. 
Wessells, N.K., Cohen, J.H., 1967. Early pancreas organogenesis: Morphogenesis, tissue 
interactions, and mass effects. Developmental Biology 15, 237-270. 
  54 
Xuan, S., Sussel, L., 2016. GATA4 and GATA6 regulate pancreatic endoderm identity 
through inhibition of hedgehog signaling. Development 143, 780-786. 
Ye, F., Duvillié, B., Scharfmann, R., 2005. Fibroblast growth factors 7 and 10 are 
expressed in the human embryonic pancreatic mesenchyme and promote the proliferation 
of embryonic pancreatic epithelial cells. Diabetologia 48, 277-281. 
Yebra, M., Montgomery, A.M.P., Diaferia, G.R., Kaido, T., Silletti, S., Perez, B., Just, M.L., 
Hildbrand, S., Hurford, R., Florkiewicz, E., Tessier-Lavigne, M., Cirulli, V., 2003. 
Recognition of the Neural Chemoattractant Netrin-1 by Integrins α6β4 and α3β1 Regulates 
Epithelial Cell Adhesion and Migration. Developmental Cell 5, 695-707. 
Yoshitomi, H., Zaret, K.S., 2004. Endothelial cell interactions initiate dorsal pancreas 
development by selectively inducing the transcription factor Ptf1a. Development 131, 807-
817. 
Young, H.M., Newgreen, D., 2001. Enteric neural crest-derived cells: origin, identification, 
migration, and differentiation. The Anatomical Record 262, 1-15. 
Zepp, J.A., Zacharias, W.J., Frank, D.B., Cavanaugh, C.A., Zhou, S., Morley, M.P., 
Morrisey, E.E., 2017. Distinct Mesenchymal Lineages and Niches Promote Epithelial Self-
Renewal and Myofibrogenesis in the Lung. Cell 170, 1134-1148.e1110. 
Zheng, Y., Ley, S.H., Hu, F.B., 2018. Global aetiology and epidemiology of type 2 diabetes 
mellitus and its complications. Nature Reviews Endocrinology 14, 88-98. 
Zhou, Q., Law, A.C., Rajagopal, J., Anderson, W.J., Gray, P.A., Melton, D.A., 2007. A 
Multipotent Progenitor Domain Guides Pancreatic Organogenesis. Developmental Cell 13, 
103-114. 
Zorn, A.M., Wells, J.M., 2007. Molecular Basis of Vertebrate Endoderm Development, in: 
Cytology, B.-I.R.o. (Ed.). Academic Press, pp. 49-111. 
 
  55 
FIGURE LEGEND 
Figure 1. The pancreatic microenvironment during embryonic development. 
Schematic representation of the developing pancreatic epithelium and surrounding 
microenvironment. This is composed by multiple cell populations, such as fibroblast-like 
mesenchymal, endothelial, immune and neural crest-derived cells, and ECM components. 
In blue, tip pancreatic cells; in grey duct cells; in purple, delaminating endocrine 
progenitors. 
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